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The synthesis of seven peptidomimetics of RGD is presented. The indolizine building block was obtained by 
condensation of allylglycine with dimethoxydihydrofuran followed by an intermolecular cyclisation. The bicyclic 
ring was functionalised with a carboxylic acid and a guanidinium appendage. The seven peptidomimetics were 
evaluated by cell-adhesion assays. 
Introduction 
Integrins are transmembrane receptors which regulate cell attachement and response to the extracel lular matrix. They 
are involved in many physiopathological processes: coagulation of blood, tumor-induced angiogenesis, osteoporosis, 
restenosis, acute renal failure, ocular diseases, metastasis formation and sickle cell anemia, and represent an interestin g 
target for therapeutic.1 
Among the various known integrins the αvβ3 and αvβ5 integrin receptors are of great interest since they are involved in 
angiogenesis, a target for cancer therapy by inhibiting vascularisation of tumors. 2 
The tripeptide Arg-Gly-Asp (RGD) is the motif of recognition of most integrins on several matrix proteins (vitronectin 
(VN), fibronectin (FN))... The specificity of each integrin depends on the conformation of the triad induced by the 
other residues.3 
To date, several inhibitors have been imagined and prepared.4 A cyclic pentapeptide (c(-RGDf[NMe]V-) Cilengitide) 
was found quite active while a lot of studies have emmerged in order to access peptidomimetics. 5 In these series of 
compounds, azabicycloalkanes have been developed as versatile scaffolds to mimic peptide conformation.6 Their 
bicyclic ring backbone gives geometry with fixed dihedral angles, on which the acid (Asp) and basic (Arg) side chains 
can be placed at an optimal distance of 13 Å allowing the recognition.  
We have been interested in developing the synthesis of several new structures as integrin inhibitors since we recently 
developed an efficient synthesis of indolizin-3-one.7 We envisaged it as a scaffold which could be converted into a 
potent integrin ligand by introducing a carboxylic and a guanidine appendage (Fig 1). 
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figure 1 
Results and discussion 
In this paper, we report the synthesis and the biological activity of RGD peptidomimetics 1. On this bicyclic 
compound, the length and the relative geometry of the two side chains bearing the acid and basic functions can be 
adapted to optimize the affinity with the receptor. The peptidomimetics were evalued in vitro by cell -adhesion assays. 
Synthesis of the indolizine building block 
The first step was the condensation in acidic medium of dimethoxydihydrofuran8 (2) with racemic allylglycine (3) 
(scheme 1). 
This condensation led to lactam 4 which was directly cyclised in refluxing formic acid to give only two 
diastereoisomers at the C7 position % 5 and 6 (60/40) which can be separated through column chromatography. 
Pratically, the crude reaction mixture was used. The formiate was hydrolysed by KHCO 3 (1.1 equivalent) in MeOH to 
yield alcools 7 and 8 in 86% yield. The hydroxyl group was protected as a benzyl or a MOM ether in good yield to 
give 9a, 10a (76 %) and 9b, 10b (87 %) respectively. 
Their reaction with NaBH4 in refluxing ethanol allowed an easy separation of the two diastereoisomers. Indeed isomer 
10a and 10b which exhibited a cis group were not reducted but just transesterified by ethanol. 12a, 12b, and 11a, 11b 
were isolated in 84% and 83% overall yield. NMR studies made it possible to establish a cis-diaxal relationship 
between the hydroxyl and ester groups in compound 10 (or 12) and could explain the chemioselectivity of the NaBH4 
reduction. 
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Scheme 1 synthesis of the indolizine building block i) HCl 1 M; ii) HCOOH, reflux, 60% (2 steps); iii) KHCO3 (1,1 eq), MeOH, 0 °C, 86%; 
iv) R1 = Bn: trichloroacetimidate (3 equiv), TfOH (0.25 equiv), C6H12/CH2Cl2, 22 h, 76%; R1 = MOM: iPr2NEt (4.5 equiv), MOMCl (4.5 
equiv), THF, rt, 2 days, 87%; v) NaBH4, EtOH, reflux, R1 = Bn, 84%, R1 = MOM, 83%. 
Functionalisation of the indolizine building block 
Having prepared the bicyclic skeleton, we had to introduce the two side chains with an appropriate relative 
configuration. An allyl group was first introduced (α to the carbonyl of the lactam) to be transformed into the 
guanidine. This allylation was performed after deprotonation using LDA in te trahydrofuran and allyl bromide (scheme 
2). Lactams 11a and 11b bearing the ether and hydroxyl functions in a trans relationship were deprotonated with 2 
equivalents of LDA to furnish, after treatment with allyl bromide, 16a + 17a (87:13, 46% yield) and 16b + 17b (71:29, 
54%) respectively. When the allylation was conducted with the diprotected derivative 13 (MOM and TBDMS ether), 
14 and 15 were isolated in improved yield and diastereoselectivity (10:90, 88%). It is noteworthy that the 
diastereoselectivity was inverted compared to the free hydroxyl series. Thus both isomer series can be easily attained 
by using protected or unprotected alcohol. In all cases, the relative configuration of the allyl group was assigned by 
NOE experiments. 
The next task was to perform the functional group interchanges to obtain the acidic and basic side chains. 
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Scheme 2 allylation of the indolizine i) Et3N, TBDMSOTf, CH2Cl2, -10 °C, 88%; ii) LDA, -78 °C, allylbromide, THF; iii) Bu4NF, THF, 
97%. 
 
We anticipated transforming the allyl group into guanidine. Furthermore, different acid side chains could be obtained 
from the same intermediates.This transformation was attempted with benzyl ether 16a. Actualy, this synthetic way was 
not useful: the yield was low (oxidation of the primary alcohol into acid) and purification of the guanidine compound 
was difficult (several chromatographies were needed). Consequently, we decided to begin with the acid side chain. 
In this sequence, we started working on the acid side chain (scheme 3). Alcohol 16a was oxided by Jones reagent to 
give the acid 18 in good yield (67%). Coupling with -Alanine ter-butylester and L-Aspartic acid di-ter-butylester 
furnished 19 (83%) and 20 (88%), respectively. 
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Scheme 3 functionalisation of the cis diastereoisomer: i) CrO3, H2SO4, acetone, 0 °C, 40 min, 67%; ii) NMM, ClCOOiBu, CH2Cl2, R1 = H, 
83%, R1 = COOtBu, 88%; iii) a) 9-BBN, b) H2O2, AcONa, R1 = COOtBu, 68%, R1 = H, 71%; iv) ADDP, PPh3, di-Boc-guanidine, toluene, 
reflux, 2h, 60%; v) DEAD, PPh3, di-Boc-guanidine, THF, rt, 64h, 92%; vi) TFA, CH2Cl2, 100%; vii)  R2 = Bn: TFA, CH2Cl2, 100%; viii) R2 
= H: a) H2 Pd/C 10%, 72 % b) TFA, CH2Cl2, 100%. 
Hydroboration of 19 or 20 gave the alcohols 21 (71%) or 22 (68%). Contrary to several reports, substitution of the 
hydroxyl group of 21 by a guanidine through a Mitsunobu reaction with DIAD/PPh3 and di-Boc- or di-Cbz-guanidine 
was proved to be unsuccessful.9 We thus investigated the more reactive reagents dipiperidin-azodicarboxylate 
(ADDP), tributylphosphine (Bu3P).
10 Surprisingly, use of these reagents led to an unexpected compound: the guanidine 
carbamate 23.11 
Eventually, starting from compound 22, use of DEAD/PPh3
4 instead DIAD/PPh3 permitted to access to the 
guanidilated product 25. Boc deprotection with trifluoroacetic acid gave two new mimics 24 and 26. Hydrogenation on 
Pd/C of 25 followed by trifluoroacetic acid treatment also gave another analogue 27. 
The same sequence was apllied to the trans diastereoisomer 17b (scheme 4). 
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Scheme 4 functionalisation of the trans diastereoisomer: i) CrO3, H2SO4, acetone, 0 °C, 40 min, 54%; ii) NMM, ClCOOiBu, CH2Cl2, 90%; 
iii) a) 9-BBN, b) H2O2, AcONa, 65%; iv) ADDP, PPh3, di-Boc-guanidine, THF,reflux, 2h, 43% v) DEAD, PPh3, di-Boc-guanidine, THF, rt, 
64h, 60%; vi) TFA, CH2Cl2, 100%; vii) TFA, CH2Cl2, 100%. 
Oxidation of alcohol 17b gave acid 28 in moderate yield (54%), which was coupled with L-glutamic acid di-ter-butylester 
(90%). Then after hydroboration of 29 (65%), subsequent reaction of thus obtained 30 with di-Boc-guanidine led to 31 
(carbamate) and 33 (guanidinium). TFA-cleavage of the tert-butoxy and tert-butoxycarbonyl groups of 31 and 33 afforded 32 
and 34, respectively 
We investigated the transformation of compounds 12a. When these esters reacted with strong bases, a carbanion was formed 
at carbon 5. First, this center was methylated by using KHMDS and methyl iodide in good yield to obtain single 
diastereoisomer 35 (scheme 5). 
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Scheme 5 allylation of the tans diaxial diastereoisomer: i) KHMDS, MeI, THF, 99%; ii) KHMDS, allylbromide, 55% dr 60:40. 
 
Then allylation was performed with the same organic base and allylbromide, the diastereoselectivity was low (de 20%) 
and the yield was moderate (55%) (scheme 5). 
The double bond of 36 and 37 was converted into guanidinium group with DEAD/PPh3 in good overall yield (54% and 87%, 
respectively, for 3 steps). Saponification of ethyl ester was very difficult because of the steric hindrance . We checked several 
bases : NaOH, KOH, KOtBu, NaSMe, LiSMe, leading to no reaction or degradation of the starting material. Indeed, acidic 
conditions were needed: hydrolysis in aqueous ethanol with 3 M hydrochloric acid at reflux for 20 h gave compounds 39 and 
41 of which the amide bond, the benzyl ether were also hydrolyzed (schema 6). These compounds 39 and 41 had been also 
considered as pontential peptidomimetics and they have been tested in adhesion assays. 
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Scheme 6 functionalisation and hydrolysis of the tans diaxial diastereoisomer i) a) 9-BBN, b) H2O2, AcONa c) DEAD, PPh3, di-Boc-
guanidine, THF, rt (38, 54%; 40, 87%); ii) EtOH/H2O, HCl 3M, 100%. 
We synthetised 7 potential peptidomimetics of RGD in racemic form, in 10 or 11 steps and in 0.6% to 3.4% total yield 
from racemic allylglycine. 
Biological test of the 7 peptidomimetics 
The compounds 24, 26, 27, 32, 34, 39 and 41 were evaluated in vitro for their ability to inhibit cell adhesion. Their 
activity was compared to that of c(RGDfV) and GRGES that were used as positive and negative competitors for cell 
adhesion. We used two different cell lines, mouse sarcoma S180 cells and human vascular endothelial Eahy926 cells. 
These cells express 1 and v3 integrins.12 The c(RGDfV) peptide strongly inhibited S180 cell adhesion to VN 
(Fig. 2A, black bars) with 19% and 5% of cell adhesion in the presence of 10  M and 200 M of its competitor, 
respectively. This cyclic peptide inhibited less efficiently S180 cell adhesion to FN-coated surface (Fig. 2B, black 
bars) with 95% and 69% of adhesion in the presence of 10 M and 500 M c(RGDfV), respectively. In contrast, the 
control peptide GRGES has no inhibitory effect on the two types of coated surfaces (Fig. 2, white bars). Among the 
peptidomimetics tested, only the 26 and 27 compounds showed inhibitory effect on S180 cell adhesion to VN but they 
are less efficient compared to the c(RGDfV). We measured 65% and 74% of adhesion in the presence of the 26 or 27 
compound at 200 M, respectively (Fig. 2A, datched bars). They did not interfere with S180 cell adhesion to FN -
coated surfaces. 
The c(RGDfV) peptide also interfered with Eahy926 adhesion to VN but to a lesser extent compared to S180 cell 
adhesion, with 74.8±7.0 and 9.2±4.4% of adhesion measured at 10 M and 200 M c(RGDfV). All compounds tested 
showed no inhibitory effect on Eahy926 adhesion to VN nor FN-coated surfaces. 
 
 
 
figure 2 
 
Conclusions 
The scaffold of indolizin-3-one was used to prepare seven structures as potential mimics of the RGD tripeptide 
sequence. These compounds were evaluated in cell adhesion test. Two of them showed some activities: they possess 
the acid and guanidine side chains in a cis relationship. This configuration corresponds to the required geometry of a 
-turn (type II). Optimisation of the length of the side chains and use of optically active allyl glycine as starting 
material are under investigation. 
Experimental section 
General experimental methods 
All commercially available reagents were used without further purification unless otherwise noted. Tetrahydrofuran 
was freshly distilled from benzophenone ketyl radical under argon prior to use. Column chromatography was 
performed with silica gel (35-70 mesh). Melting points are reported uncorrected. 
NMR spectra were recorded on 300 and 400 MHz spectrometers Bruker Avance. Chemical shifts are reported in ppm. 
Coupling constants (J values) are reported in Hertz. 13C and 1H peak assignments were made based on DEPT, HMQC, 
HSQC, HSBC and NOESY data and IR spectra were recorded on a FT-IR spectrometer Perkin Elmer 1600. 
MS experiments were performed on a Q-Tof Micromass-1 spectrometer. 
(5S*,7S*,8aR*)-7-hydroxy-3-oxo-octahydro-indolizin-5-carboxylic acid methyl ester 7 and (5S*,7R*,8aR*)-7-hydroxy-
3-oxo-octahydro-indolizin-5-carboxylic acid methyl ester 8 
To a solution of formiates 5 and 6 (10.91 g, 45.2 mmol, 1.0 equiv) in 210 mL of anhydrous methanol was added solid 
KHCO3 (4.54 g, 45.4 mmol, 1.0 equiv) at 0 °C and the reaction was stirred 40 min at 0 °C. KHCO3 was filtered and the 
filtrate was concentrated in vacuo. Purification by flash column chromatography on silica gel (EtOAc-MeOH = 95:5 
then 90:10) gave 7 and 8 as a yellow solid (8.3 g, 86%). 
A sample of each diastereoisomer was obtained 
8: Rf = 0,3 (AcOEt/MeOH 90/10) mp: 127  C; 
1H NMR (CDCl3, 300 MHz) δH 1.30 (1H, ddd, J = 13.8, 12.0, 2.2 Hz, 
H8ax); 1.55 (1H, dddd J = 12.4, 9.8, 9.8, 8.5 Hz, H1); 1.76 (1H, ddd, J = 14.3, 7.0, 2.2 Hz, H6ax); 2.01 (1H, dm, J = 13.4 
Hz, H8eq), 2.23 (1H, dddd, J = 12.3, 9.3, 7.1, 3.0 Hz, H1); 2.3-2.5 (3H, m, 2H2 H6); 3.67 (3H, s, OMe); 4.08 (1H, dddd, 
J= 11.8, 8.0, 8.0, 3.5 Hz, H8a); 4.19 (1H, m, H7eq); 4.68 (1H, d(l), J = 6.0 Hz, H5). 
13C NMR (75 MHz, CDCl3) c 25.8 
(C1); 30.2 (C2); 32.7 (C6); 38.8 (C8); 48.1 (C5); 49.2 (C8a); 52.4 (COMe); 63.7 (C7); 171.9 175.3 (CO C3). IR (NaCl disc, 
cm-1): max = 3388, 2962, 1749, 1665, 1441, 1313, 1215, 1090, 1071. MS (ES
+): m/z = 236 ([MNa]+). HRMS (ES+, 
[MNa]+): Calcd for C10H15NO4 236.0899 Found 236.0893. 
 
7: Rf = 0,3 (AcOEt/MeOH 90/10) mp: 94 °C. 
1H NMR (CDCl3, 300 MHz): δH 1.1 (1H, ddd, J = 11.7, 11.7, 11.7 Hz, 
H8ax); 1.48 (1H, m, H6); 1.6 (1H, m, H1); 2.09 (1H, bd, J = 11.8 Hz, H8eq); 2.2 (1H, m, H1); 2.38 (3H, m, 2H2 H6); 3.66 
(4H, bs, OMe H7); 3.75 (1H, dddd, J= 7.5, 7.5, 7.5, 7.5 Hz, H8a); 4.8 (1H, d(l), J = 5.7 Hz, H5). 
13C NMR (75 MHz, 
CDCl3) C 25.5 (C1); 30.4 (C2); 34.7 (C6); 41.8 (C8); 50.2 (C5); 52.6 (OMe); 53.9 (C8a); 65.2 (C7); 170.9 174.8 (CO 
C3). IR (NaCl disc, cm
-1): max = 3432, 2952, 1736, 1666, 1432, 1213. HRMS (ES
+, [MNa]+): Calcd for C10H15NO4 
236.0899 Found 236. 0909. 
(5S*,7S*,8aR*)-7-benzyloxy-3-oxo-octahydro-indolizin-5-carboxylic acid methyl ester 9a and (5S*,7R*,8aR*)-7-
benzyloxy-3-oxo-octahydro-indolizin-5-carboxylic acid methyl ester 10a 
Alcohols 7 and 8 (10.7g, 50.4 mmol) were dissolved in 40 mL of dichloromethane under argon, 80 mL of cyclohexane 
were added. At rt, 19 mL (102 mmol, 2 equiv) of benzyl-trichloroacetimidate were added, followed by 440 μL (5 
mmol, 0.1 equiv) of triflic acid. The mixture was refluxed for 16 h, 3 mL of benzyl-trichloroacetimidate was further 
added and the reflux was continued for 20 h. The mixture was filtered on silica gel and washed with dichloromethane. 
The filtrate was evaporated and purification by flash column chromatography on silica gel (EtOAc-cyclohexane-
MeOH = 80: 15: 5) gave 9a and 10a as a colourless oil (13.6 g, 89%). 
9a: Rf = 0.49 (AcOEt/cyclohexane/MeOH 80/15/5).
1H NMR (CDCl3, 300 MHz) δH 1.16 (1H, ddd, J = 11.7, 11.7, 11.7 
Hz, H8ax); 1.58 (2H, m, H1 H6ax); 2.2 (2H, m, H1 H8eq); 2.38 (2H, m, H2); 2.55 (1H, dm, J= 7, 5 Hz, H6eq); 3.44 (1H, 
dddd, J = 11.3, 11.3, 3.8, 3.8 Hz, H7ax); 3.66 (3H, s, OMe); 3.73 (1H, m, H8a); 4.51 (2H, s, CH2Ph); 4.89 (1H, d, J = 
5.6 Hz, H5); 7.26 (5H, m, Ar). 
13C NMR (75 MHz, CDCl3) C 25.2 (C1); 29.9 (C2); 31.7 (C6); 38.8 (C8); 49.8 (C5); 52.2 
(OMe); 53.3 (C8a); 69.9 (CH2Ph); 72.0 (C7); 127.4 (3CAr); 128.1 (CAr); 137.8 (CArquat); 170.9 174.8 (CO C3). IR (NaCl 
disc, cm-1): max = 3352, 2926, 1732, 1682, 1454, 1366, 1291, 1208, 1110.  HRMS (ES
+, [MNa]+): Calcd for 
C17H21NO4 326.1368 Found 326.1365. 
 
10a: Rf = 0.43 (AcOEt/cyclohexane/MeOH: 80/15/5) 
1H NMR (CDCl3, 300 MHz): δH 1.29 (1H, ddd, J = 13.7, 12.0, 
2.2 Hz, H8ax); 1.57 (1H, dddd, J = 12.4, 10.5, 10.5,, 8.7 Hz, H1); 1,71 (1H, ddd, J = 14.3, 7.0, 2.1 Hz, H6ax); 2.19 (1H, 
dddd, J= 13.4, 13.4, 13.4, 13.4 Hz, H8eq); 2.28 (1H, m, H1); 2.40 (2H, m, 2H2); 2.71 (1H, dddd, J = 14.2, 3.3, 1.7, 1.7 
Hz, H6eq); 3.51 (3H, s, OMe); 3.84 (1H, bs, H7eq); 4.11 (1H, dddd, J= 11.8, 8.4, 8.4, 3.6 Hz, H8a); 4.41 (1H, d, J = 11.8 
Hz, CH2Ph); 4.51 (1H, d, J = 11.8 Hz, CH2Ph); 4.74 (1H, d, J = 6.0 Hz, H5); 7.25 (5H, m, HAr). 
13C NMR (75 MHz, 
CDCl3) C 25.9 (C1); 29.3 (C6); 30.1 (C2); 37.1 (C8); 48.2 (C5); 49.4 (C8a); 52.0 (OMe); 70.1 (CH2Ph); 70.7 (C7); 
127.0(2CAr); 127.4 (CAr); 128.2 (CAr); 138.2 (CArquat); 171.0 174.6 (CO C3). IR (NaCl disc, cm
-1): max = 3448, 2951, 
1747, 1696, 1417, 1359, 1293, 1209, 1093. MS (ES+): m/z 326 ([MNa]+). 
(5S*,7S*,8aR*)-7-methoxymethoxy-3-oxo-octahydro-indolizin-5-carboxylic acid methyl ester 9b and (5S*,7R*,8aR*)-
7-methoxymethoxy-3-oxo-octahydro-indolizin-5-carboxylic acid methyl ester 10b 
To alcohols 7 and 8 (371 mg, 1.74 mmol) dissolved in 7 mL of anhydrous THF under argon and cooled to 0  °C, was 
successively added diisopropylethylamine (860 μL, 5.2 mmol, 3 equiv) and chloromethoxymethane (395 μL, 5.2 
mmol, 3 equiv). The mixture was stirred for 20 h, 1.5 equiv of each reagent was added again, stirring was continued 
for 16 additionnal hours. After addition of a satured solution of NH4Cl, the ester was extracted by CH2Cl2, the organic 
layers were dried (MgSO4) and concentrated under vacuum. Purification by flash column chromatography on silica gel 
gave 388 mg (87 %) of 9b and 10b. 
10b: Rf = 0.39 (AcOEt/cyclohexane/MeOH: 80/15/5). 
1H NMR (CDCl3, 300 MHz): δH 1.25 (1H, ddd, J = 13.6, 11.7, 
1.9 Hz, H8ax); 1.52 (1H, m, H1); 1.66 (1H, ddd, J = 14.4, 7.0, 2.0 Hz, H6); 2.03 (1H, dm, J= 13.4 Hz, H8eq); 2.21 (1H, 
m, H1); 2.26-2.44 (2H, m, 2H2); 2.48 (1H, bd, J= 14.4 Hz, H6eq); 3.26 (3H, s, COOMe); 3.63 (3H, s, OMe); 4.0 (2H, m, 
H7 H8a); 4.41 (1H, d, J = 6.8 Hz, OCH2O); 4.55 (1H, d, J = 6.8 Hz, OCH2O); 4.66 (1H, d, J = 6.6 Hz, H5). 
13C NMR 
(75 MHz, CDCl3) C 25.9 (C1); 29.9 (C6); 30.2 (C2); 37.2 (C8); 48.2 (C5); 49.5 (C8a); 52.2 (CH2OMe); 55.5 (OMe); 
67.7 (C7); 94.0 (OCH2O); 171.2 174.9 (CO C3). IR (NaCl disc, cm
-1): max = 3478, 2950, 1747, 1682, 1417, 1209, 
1038, 919. MS (ES+): m/z 280 ([MNa]+). HRMS (ES+, [MH]+): Calcd for C12H19NO5 258.1341 Found 258.1351. 
 
9b: Rf = 0.46 (AcOEt/cyclohexane/MeOH 80/15/5).
1H NMR (CDCl3, 300 MHz) δH 1.19 (1H, ddd, J = 11.7, 11.7, 11.7 
Hz, H8ax); 1.61 (2H, m, H1 H6); 2.24 (2H, m, H1 H8); 2.3-2.5 (3H, m, H2  H6); 3.34 (3H, s, OMe); 3.63 (1H, m, H7); 
3.72 (3H, s, OMe); 3.80 (1H, m, H8a); 4.65 (2H, s, OCH2O); 4.9 (1H, d, J = 5.7 Hz, H5). 
13C NMR (75 MHz, CDCl3) 
C 25.5 (C1); 30.2 (C2); 32.5 (C6); 39.7 (C8); 50.1 (C5); 52.2 (OMe); 53.5 (C8a); 70.9 (C7); 95.0 (OCH2O); 170.9 174.2 
(CO C3). 
(5S*,7R*,8aR*)-7-benzyloxy-3-oxo-octahydro-indolizin-5-carboxylic acid ethyl ester 12a 
To a mixture of 9a and 10a (4.7 g, 15.5 mmol, cis/trans: 20/80) dissolved in 250 mL of absolute alcohol, sodium 
borohydride (6g, 159 mmol, 10 equiv) was added. The mixture was refluxed for 3 h. After cooling, the solution was 
concentrated under vacuum, borane precipitates were filtrated and washed with CH2Cl2. The filtrate was concentrated 
under reduced pressure and the residue was diluted with CH2Cl2 and H2O, extracted twice by CH2Cl2. The organic 
phase was dried with MgSO4 and evaporated to dryness, whereafter the residue was purified by flash chromatography 
on silica gel (EtOAc/MeOH, 99/1 to 90/10) to afford 780 mg of 11a as a ligh yellow oil (16%, 80% from 10a ) and 2.9 
g of 12a as a white solid 68%, 85% from 9a). 
Rf = 0.28 (AcOEt); 
1H NMR (CDCl3, 300 MHz): δH 1.11 (3H, t, J = 7.2, CH3); 1.28 (1H, ddd, J = 13.8, 12.0, 2.3 Hz, 
H8ax); 1.56 (1H, dddd, J = 12.4, 9.6, 9.6, 9.1 Hz , H1); 1.70 (1H, ddd, J = 14.4, 7.1, 2.2 Hz, H6ax); 2.10 (1H, ddd, J= 
13.4, 13.4, 13.4 Hz, H8eq); 2.25 (1H, dddd, J = 12.2, 9.4, 6.8, 2.7 Hz, H1); 2.42 (2H, m, 2H2); 2.71 (1H, dddd, J = 14.3, 
3.2, 1.6, 1.6 Hz, H6equ); 3.83 (1H, m, H7); 3.92 (1H, dq, J = 10.7, 7.2, OCH2); 4.02 (1H, dq, J = 10.7, 7.2, OCH2); 4.11 
(1H, dddd, J= 11.8, 8.5, 8.5, 3.4 Hz, H8a); 4.41 (1H, d, J= 11.9 Hz, CH2Ph); 4.52 (1H, d, J= 11.9 Hz, CH2Ph); 4.72 
(1H, bd, J = 5.9 Hz, H5); 7.27 (5H, m, Ar). 
13C NMR (75 MHz, CDCl3) C 14.0 (CH3); 26.1 (C1); 29.3 (C6); 30.4 (C2); 
37.1 (C8); 48.4 (C5); 49.6 (C8a); 61.3 (CH2O); 70.2 (CH2Ph); 70.6 (C7); 94.0 (OCH2O); 127.1(2CAr); 127.5 (CAr); 128.3 
(2CAr); 138.4 (CArquat); 170.7 174.9 (CO C3). IR (NaCl disc, cm
-1): max = 3468, 2935, 1742, 1694, 1417, 1292, 1198, 
1093. MS (ES+): m/z 340 ([MNa]+). HRMS (ES+, [MNa]+): Calcd for C18H23NO4 340.1525 Found 340.1534. 
(5S*,7S*,8aR*)-7-benzyloxy-5-hydroxymethyl-hexahydro-indolizin-3-one 11a 
Rf = 0.39 (AcOEt/MeOH: 90/10); mp: 95 °C. 
1H NMR (CDCl3, 300 MHz): δH 1.17 (1H, ddd, J = 11.8, 11.8, 11.8 Hz, 
H8ax); 1.47 (1H, ddd, J = 12.9, 11.6, 6.6 Hz , H6ax); 1.59 (1H, dddd, J = 12.5, 9.6, 9.6, 7.3 Hz, H1); 2.2 (3H, m, H6 H8eq 
H1); 2.38 (2H, m, H2); 3.56 (2H, d, J = 7.0 Hz, CH2O); 3.7 (2H, m, H7 H8a); 4.35 (1H, ddd, J = 6.7, 6.7, 6.7 H5); 4.54 
(2H, s, OCH2Ph); 7.30 (5H, m, Ar). 
13C NMR (75 MHz, CDCl3) C 19.7 (C1); 29.2 (C2); 29.9 (C6); 38.4 (C8); 48.5 
(C5); 52.0 (C8a); 60.5 (CH2O); 68.7 (CH2Ph); 70.8 (C7); 126.2 (3CAr); 127.2 (2CAr); 137.6 (CArquat); 174.9 (C3). IR 
(KBr disc, cm-1): max = 3319, 2943, 1742, 1664, 1458, 1290, 1100, 1074, 740. HRMS (ES
+, [MH]+): Calcd for 
C16H21NO3 276.1600 Found 276.1602. Anal. Calcd. for: C16H21NO3 C, 69.79; H, 7.69; N, 5.09. Found: C, 69.33; H, 
7.74; N 4.99%. 
(5S*,7R*,8aR*)-7-methoxymethoxy-3-oxo-octahydro-indolizin-5-carboxylic acid ethyl ester 12b 
To a mixture of 9b and 10b 128 mg (0.5 mmol, cis/trans: 74/26) dissolved in 10 mL of absolute alcohol, sodium 
borohydride (189 mg, 5 mmol, 10 equiv) was added. The solution was refluxed for 3 h. After cooling, the solution was 
concentrated under vacuum, borane precipitates were filtrated and washed with CH 2Cl2. The filtrate was concentrated 
under reduced pressure; the residue was diluted with CH2Cl2 and 10 mL of H2O, extracted twice by CH2Cl2. The 
organic phase was dried with MgSO4 and evaporated to dryness, whereafter the residue was purified by flash 
chromatography on silica gel (EtOAc/cyclohexane 95/5, 99/1 to EtOAc/MeOH 95/5) to afford 86 mg of 12b as a 
colorless oil (63%, 86% from 10b) and 23 mg of 11b as a colorless oil 20%, 77% from 9b). 
Rf = 0.38 (AcOEt/cyclohexane/MeOH: 80/15/5). 
1H NMR (CDCl3, 300 MHz): δH 1.10 (3H, t, J = 7.2 Hz, CH2CH3); 
1.25 (1H, ddd, J = 13.8, 12.1, 2.2 Hz, H8ax); 1.43 (1H, dddd, J = 12.4, 9.8, 9.8, 8.9 Hz, H1); 1.58 (1H, ddd, J = 14.4, 
7.1, 2.3 Hz, H6); 1.95 (1H, ddd, J= 13.4, 13.4, 13.4 Hz, H8eq); 2.12 (1H, dddd, J = 12.3, 8.3, 5.4, 2.6 Hz, H1); 2.22 (1H, 
ddd, J = 17.0, 9.7, 2.6 Hz, H2); 2.29 (1H, m, H2); 2.40 (1H, dddd, J= 14.4, 3.3, 1.7, 1.7 Hz, H6eq); 3.19 (3H, s, OMe); 
3.89 (2H, m, H7 H8a); 3.97 (1H, dq, J = 10.8, 7.1 Hz, CH2O); 4.03 (1H, dq, J = 10.8, 7.2 Hz, CH2O); 4.27 (1H, d, J = 
6.8 Hz, OCH2O); 4.43 (1H, d, J = 6.7 Hz, OCH2O); 4.48 (1H, dd, J = 6.6, 1.1 Hz, H5). 
13C NMR (75 MHz, CDCl3) C 
14.1 (CH3CH2O); 26.0 (C1); 29.3 (C6); 30.3 (C2); 37.1 (C8); 48.3 (C5); 49.5 (C8a); 55.4 (CH2OMe); 61.1 (OCH2CH3); 
67.7 (C7); 93.9 (OCH2O); 170.4 174.8 (CO C3). IR (NaCl disc, cm
-1): max = 3468, 2938, 1744, 1694, 1417, 1292, 
1199, 1038. MS (ES+): m/z 294 ([MNa]+). HRMS (ES+, [MH]+): Calcd for C13H21NO5 272.1498 Found 272.1494. 
(5S*,7S*,8aR*)-5-hydroxymethyl-7-methoxymethoxy-hexahydro-indolizin-3-one 11b 
Rf = 0.09 (AcOEt/cyclohexane/MeOH: 80/15/5). 
1H NMR (CDCl3, 300 MHz): δH 1.13 (1H, ddd, J = 11.7, 11.7, 11.7 
Hz, H8ax); 1.44 (1H, ddd, J = 13.2, 13.2, 6.6 Hz, H6); 1.58 (1H, m, H1); 2.05 (1H, bd, J= 13.2 Hz, H6); 2.18 (2H, m, H1 
H8eq); 2.35 (2H, m, 2 H2); 3.30 (3H, s, OMe); 3.57 (2H, bd, J= 6.7 Hz, CH2OH); 3.67 (1H, m, H8a); 3.83 (1H, m, H7); 
4.30 (1H, ddd, J = 6.6, 6.6, 6.6 Hz, H5); 4.62 (2H, bs, OCH2O). 
13C NMR (75 MHz, CDCl3) C 25.4 (C1); 30.5 (C2); 
31.6 (C6); 40.3 (C8); 49.7 (C5); 53.2 (C8a); 55.4 (CH2OMe); 62.5 (CH2OH); 70.4 (C7); 94.9 (OCH2O); 175.0 (C3). IR 
(NaCl disc, cm-1): max = 2943, 1672, 1656, 1421, 1287, 1111, 1064. HRMS (ES
+, [MH]+): Calcd for 
C11H19NO4 252.1212 Found 272.1205. 
(2S*,5S*,7S*,8aR*)-2-Allyl-7-benzyloxy-5-hydroxymethyl-hexahydro-indolizin-3-one 16a and (2R*,5S*,7S*,8aR*)-2-
Allyl-7-benzyloxy-5-hydroxymethyl-hexahydro-indolizin-3-one 17a 
A 15 mL LDA solution in THF (from diisopropylamine (22.1 mmol; 3.1 mL; 2.1 équiv) and BuLi 1.94 M in hexane 
(22.1 mmol; 11.4 mL) cooled to -78 °C was cannulated to amide 11a (10.5 mmol; 2.9 g) in THF (35 mL) maintained at 
-78 °C under argon. The solution was stirred at the same temperature for 20 min and allyl bromide (11.6 mmol; 1 mL; 
1.1 equiv). was slowly added. The mixture was stirred at -78 °C for 2h and then treated with an aqueous saturated 
NH4Cl solution (20 mL). The aqueous phase was extracted several times with CH2Cl2. The organic phase was then 
dried with MgSO4 and the solvent removed in vacuo. The residue was purified by flash chromatography 
(AcOEt/MeOH: 99.5/0.5 to 95/5) to give the two diastereomeric compounds 16a and 17a in a 87/13 ratio and a 46% 
overall yield. (827 mg of pure 16a as a pale yellow oil, 97 mg of pure 17a as a pale yellow oil and 778 mg  of a 
mixture were isolated). 
16a: Rf = 0.42 (AcOEt/MeOH: 98/2). 
1H NMR  (CDCl3, 400 MHz) δH (ppm): 1.17 (1H, ddd, J = 11.6, 11.6, 11.6 Hz, 
H8ax); 1.51 (1H, m, H6); 1.79 (1H, m, H1); 2.01 (1H, m, H1); 2.13-2.28 (3H, m, H6 H8 CH2CH=CH2); 2.44 (1H, m, 
CH2CH=CH2); 2.59 (1H, m, H2); 3.1 (1H, bs, H-O); 3.5-3.8 (4H, m, CH2OH H8a H7); 4.38 (1H, ddbd, J = 6.8, 6.8, 6.8 
Hz, H5); 4.55 (2H, s, CH2Ph); 5.06 (1H, bd, J =9.1 Hz, CH2=CH); 5.09 (1H, bd, J =9.1 Hz, CH2=CH); 5.77 (1H, 
dddd, J= 16.0, 9.0, 7.0, 7.0 Hz, CH2=CH); 7.27 (5H, m, Ar). 
13C NMR (75 MHz, CDCl3) C 30.3 (C1); 30.8 (C6); 35.8 
(CH2CH=CH2); 39.4 (C8); 40.9 (C2); 49.7 (C5); 51.4 (C8a); 62.4 (CH2OH); 70.1 (CH2Ph); 71.8 (C7); 117.3 (CH2=CH); 
127.5; 127.6; 128.3 (2CAr CAr 2CAr); 135.0 (CH2=CH); 138.1 (CArquat); 176.4 (C3). IR (NaCl disc, cm
-1): max 3391, 
2942, 1681, 1650, 1454, 1367, 1280, 1094, 917, 739. MS (ES+): m/z 338 ([MNa]+). HRMS (ES+, [MNa]+), Calcd for 
C19H25NO3 338.1732 Found 338.1717. 
 
17a: Rf = 0.5 (AcOEt/MeOH : 98/2).
 1H (CDCl3, 300 MHz): δH 1.11 (1H, ddd, J = 11.7, 11.7, 11.7 Hz, H8ax); 1.3 (1H, 
ddd, J = 11.3, 11.3, 11.3 Hz, H1); 1.49 (1H, ddd, J = 13.1, 11.6, 6.6 Hz, H6); 2.1 (2H, m, H6 CH2CH=CH2); 2.3 (2H, 
m, H1 H8); 2.57 (2H, m, H2 CH2CH=CH2); 3.1 (1H, bs, H-O); 3.57 (3H, m, H8a CH2OH); 3.68 (1H, dddd, J= 11.2, 
11.2, 4.0, 4.0 Hz, H7); 4.37 (1H, ddd, J= 6.7, 6.7, 6.7, Hz, H5); 4.52 (2H, s, CH2Ph); 5.02 (1H, dd, J= 10.1, 1.6 Hz, H14 
CH2cis=CH); 5.05 (1H, dd, J= 17.1, 1.6 Hz CH2trans=CH); 5.71 (1H, dddd, J= 16.9, 10.1, 6.8, 6.8 Hz, CH2=CH); 7.3 
(5H, m, Ar). 13C NMR (100 MHz, CDCl3) C 31.1 (C6); 32.4 (C1); 35.4 (CH2CH=CH2); 40.0 (C8); 41.3 (C2); 49.9 
(C5) ; 51.5 (C8a) ; 62.5 (CH2OH); 70.4 (CH2Ph); 72.0 (C7); 117.0 (CH2=CH); 127.7 (2CAr); 127.8 (CAr); 128.5 (2CAr); 
135.5 (CH2=CH); 138.4 (CArquat); 176.0 (C3). IR (NaCl disc, cm
-1): max 3396, 2927, 2867, 1666, 1454, 1367. MS 
(ES+): m/z 316 ([MH]+); 338 ([MNa]+); 354 ([MK]+). HRMS (ES+, [MNa]+), Calcd for C19H25NO3 338.1732 found 
338.1732. 
(2S*,5S*,7S*,8aR*)-2-Allyl-5-hydroxymethyl-7-methoxymethoxy-hexahydro-indolizin-3-one 16b and 
(2R*,5S*,7S*,8aR*)-2-Allyl-5-hydroxymethyl-7-methoxymethoxy-hexahydro-indolizin-3-one 17b 
The same experimental procedure as described for allylation was applied to lactam 11b (100 mg; 0.43 mmol) using 
LDA prepared from diisopropylamine (152 μL; 1.07 mmol; 2.5 equiv) and butyllithium 2.28 M (471 μL; 1.07 mmol; 
2.5 equiv). Stirring was maintained 3h after addition of allyl bromide (41 μL; 0.47 mmol; 1.1 equiv). Flash 
chromatography on silica gel (AcOEt/MeOH: 95/5) allowed the isolation of 16b and 17b as a 71/29 ratio in a 54% 
yield. (17b: 8 mg as a pale yellow oil, 16b: 22 mg as a pale yellow oil and 32 mg of a mixture). 
16b: Rf = 0.38 (AcOEt/MeOH: 90/10); 
1H NMR (CDCl3, 300 MHz) δH 1.15 (1H, ddd, J = 11.7, 11.7, 11.7, Hz, H8ax); 
1.33 (1H, m, H1); 1.55 (1H, ddd, J = 13.2 , 11.7 , 6.7 Hz, H6ax); 2.11 (2H, m, H6eq CH2 CH=CH2); 2.28 (1H, bd, J = 
12.1 Hz,  H8eq); 2.37 (1H, ddd, J = 12.6, 8.5, 6.7 Hz, H1); 2.61 (2H, m, H2  CH2 CH=CH2); 3.39 (3H, s, CH2OMe); 
3.62 (1H, m, H8a); 3.66 (2H, d, J = 6.9 Hz, CH2OH); 3.87 (1H, dddd, J=11.4, 11.4, 4.3, 4.3 Hz, H7ax); 4.4 (1H, ddd, 
J=6.7, 6.7, 6.7 Hz, H5eq); 4.7 (2H, s, OCH2O); 5.06 (1H, dd, J = 10.1, 1.6 Hz, CH2=CH); 5.11 (1H, dd, J=17.1, 1.6 Hz, 
CH2=CH); 5.27 (1H, dddd, J = 17.0, 10.1, 6.8, 6.8 Hz, CH2=CH). 
13C NMR (CDCl3, 100 MHz) C 31.6 (C6); 32.6 
(C1); 35.4 (CH2 CH=CH2); 40.4 (C8); 41.3 (C2); 49.8 (C5); 51.3 (C8a); 55.5 (CH2OMe); 63.5 (CH2OH); 70.5 (C7); 95.0 
(OCH2O); 126.9 (CH2=CH); 135.5 (CH2=CH); 176.3 (C3). IR (NaCl disc, cm
-1): max = 3403, 2931, 1667, 1436, 1276, 
1151, 1105, 1039, 916. MS (ES+): m/z 270 ([MH]+) 292 ([MNa]+). HRMS (ES+, [MNa]+): Calcd for C14H23NO4 
292.1525 Found :292.1534. 
 
From 15 : to silyl compound 15 (35 mg; 0.87 mmol) dissolved in 14 mL of anhydrous THF was added slowly a 
solution 1 M of tetrabutylammonium fluoride in THF (2.6 mL; 2.6 mmol; 3 equiv) at 0 °C. Stirring was continued 30 
min after removal of the ice bath. At 0 °C 7 mL of water was added, the mixture was extracted 3 times with 
dichloromethane. The organic phase was dried with MgSO4 and the solvent removed in vacuo. The residue was 
purified by flash chromatography (AcOEt/MeOH: 97/3) to give 17b as a pale yellow oil (226 mg, 97%). 
 
17b: Rf = 0.44 (AcOEt/MeOH : 90/10).1H NMR (CDCl3, 300 MHz): δH 1.16 (1H, ddd, J =11.6, 11.6, 11.6 Hz, H8ax); 
1.48 (1H, ddd, J = 13.1, 11.7, 6.7 Hz, H6ax ); 1.77 (1H, ddd, J = 13.1, 9.5, 6.3 Hz, H1); 2.0 (1H, m, H1); 2.07 (1H, ddd, 
J = 13.3, 13.3, 13.3 Hz, H6eq); 2.2 (2H, m, H8eq , CH2 CH=CH2); 2.45 (1H, m, CH2 CH=CH2); 2.57 (1H, dddd, , J=4.3, 
4.3, 8.8, 8.8 Hz, H2); 3.34 (3H, s, CH2OMe); 3.61 (2H, d, J = 7.2 Hz, CH2OH); 3.65 (1H, m, H8a); 3.85 (1H, dddd, 
J=11.3, 11.3, 4.2, 4.2 Hz, H7ax); 4.38 (1H, ddd, J = 6.7, 6.7, 6.7 Hz, H5eq); 4.65 (2H, d, J = 1.2 Hz, OCH2O); 5.06 (2H, 
m, CH2=CH); 5.76 (1H, dddd, J = 17.0, 10.1, 7.0, 7.0 Hz, CH2=CH). 
13C NMR (75 MHz, CDCl3) C 30.3 (C1); 31.4 
(C6); 35.8 (CH2-CH=CH2); 40.0 (C8); 40.9 (C2); 49.7 (C5); 51.4 (C8a); 55.4 (CH2OMe); 62.5 (CH2OH); 70.4 (C7); 94.8 
(OCH2O); 117.3 (CH2=CH); 135.1 (CH2=CH); 176.4 (C3). IR (NaCl disc, cm
-1): max = 3397, 2943, 1684, 1441, 1279, 
1151, 1105, 1034, 917. MS (ES+): m/z 270 ([MH]+). HRMS (ES+. [MNa]+): Calcd for C14H23NO4  292.1525 Found: 
292.1520. 
(5S*,7S*,8aR*)-5-(tert-butyl-dimethyl-silyloxymethyl)-7-methoxymethoxy-hexahydro-indolizin-3-one 13 
Alcohol 11b (343 mg; 1.5 mmol) in CH2Cl2 (10 mL) was cooled to -10 °C and triethylamine (525 μL; 3.75 mmol; 2.5 
equiv) and tert-butyldimethylsilyl triflate (444 μL, 1.95 mmol; 1.3 equiv) were added. The solution was stirred 
between -5 et -10 °C for 30 min. and an aqueous saturated NaHCO3 solution (3 mL) was added. The aqueous solution 
was extracted with CH2Cl2. The organic phase was washed with water (2 mL) and then NaCl solution, dried and the 
solvent removed in vacuo. The residue was purified by flash-chromatography on silica gel (Ether/MeOH: 99.5/0.5). 
Silyl ether 13 was obtained as a pale yellow oil in 88% yield (453 mg). 
Rf = 0.45 (Ether/MeOH: 99/1). 
1H NMR (CDCl3, 300 MHz): δH 0.04 (3H, s, SiMe); 0.06 (3H, s, SiMe); 0.89 (9H, s, 
SitertBu); 1.15 (1H, ddd, J = 11.8, 11.8, 11.8 Hz, H8ax); 1.49 (1H, ddd, J = 13.2, 11.8, 6.7 Hz, H6ax); 1.61 (1H, dddd, J 
= 12.4, 9.5, 9.5, 7.5 Hz, H1); 2.20 (3H, m, H6eq H8eq H1); 2.37 (2H, m, 2H2); 3.36 (3H, s, OMe); 3.61 (1H, dd, J = 10.0, 
4.7 Hz, CH2O); 3.68 (1H, dd, J = 10.0, 6.0 Hz, CH2OH); 3.76 (1H, dddd, J = 11.5, 7.3, 7.3, 3.1 Hz, H8a); 4.06 (1H, 
dddd, J = 11.3, 11.3, 4.2, 4.2 Hz, H7ax); 4.30 (1H, ddd, J = 5.8, 5.8, 5.8 Hz, H5eq); 4.68 (2H, s, OCH2O). 
13C NMR 
(CDCl3, 100 MHz) C -5.49 , -5.53 (2 SiMe); 18.1 (SiC(CH3)3); 25.7 (C1); 25.9 (3 SiC(CH3)3); 30.5 (C2); 32.1 (C6); 
40.1 (C8); 49.0 (C5); 54.2 (C8a); 55.3 (OMe); 64.0 (CH2O); 70.5 (C7); 94.8 (OCH2O); 173.8 (C3). IR (NaCl disc, cm
-1): 
max = 2886, 1689, 1416, 1257, 1154, 1103, 1041, 837, 777. MS (ES
+): m/z 366 ([MNa]+). HRMS (ES+. [MNa]+): 
Calcd for C17H33NO4Si 366.2077 Found 366.2072. 
(2S*,5S*,7S*,8aR*)-2-Allyl-5-(tert-butyl-dimethyl-silyloxymethyl)-7-methoxymethoxy-hexahydro-indolizin-3-one 14 
and (2R*,5S*,7S*,8aR*)-2-Allyl-5-(tert-butyl-dimethyl-silyloxymethyl)-7-methoxymethoxy-hexahydro-indolizin-3-one 
15 
The same experimental procedure as described for allylation was applied to lactame 13 (120 mg; 0.35 mmol) using 
LDA prepared from diisopropylamine (63 L; 0.45 mmol; 1.3 equiv) and  butyllithium 2.3 M (195 L; 0.45 mmol; 1.3 
equiv). Stirring was maintained 3h after addition of allyl bromide (33 L; 0.39 mmol; 1.1 equiv). Flash 
chromatography on silica gel (ether) allowed the isolation of 15 and 14 as a 90/10 ratio in a 88% yield. (14: 12 mg as a 
yellow oil, 15: 106 mg as yellow oil. 
(2R*,5S*,7R*,8aR*)-15: Rf = 0.66 (AcOEt). 
1H NMR (CDCl3, 300 MHz): δH 0.04 (3H, s, SiMe); 0.05 (3H, s, SiMe); 
0.87 (9H, s, SitertBu); 1.1 (1H, ddd, J = 11.8 Hz, H8ax); 1.47 (1H, ddd, J = 13.6, 11.6, 6.9 Hz, H6ax); 1.73 (1H, ddd, J = 
13.0, 11.6, 6.9 Hz, H1); 1.96 (1H, ddd, J = 12.9, 7.6, 4.1 Hz, H1); 2.17 (3H, m, H6  CH2 CH=CH2  H8); 2.48 (1H, m, 
CH2 CH=CH2); 2.52 (1H, m, H2); 3.32 (3H, s, OMe); 3.60 (1H, dd, J = 10.0, 4.7 Hz, CH2O); 3.65 (1H, dd, J = 10.0, 
5.8 Hz, CH2O); 3.70 (1H, m, H8a); 4.05 (1H, dddd, J = 11.3, 11.3, 4.3, 4.3 Hz, H7ax); 4.29 (1H, ddd, J = 5.6, 5.6, 5.6 
Hz, H5ax); 4.64 (2H, d, J = 0.6 Hz, OCH2O); 5.06 (2H, m, CH2=CH); 5.74 (1H, dddd, J =
  16.9, 10.1, 6.8, 6.8 Hz, 
CH2=CH). 
13C NMR (75 MHz, CDCl3) C -5.6 (2SiMe); 18.1 (SiC(CH3)3); 25.8 (SiC(CH3)3); 30.5 (C1); 32.1 (C6); 
35.9 (CH2 CH=CH2); 39.8 (C8); 40.7 (C2); 49.0 (C5); 52.5 (C8a); 55.6 (OMe); 64.4 (CH2O); 70.6 (C7); 94.6 (OCH2O); 
117.1 (CH2=CH); 135.2 (CH2=CH); 175.1 (C3). IR (NaCl disc, cm
-1): max = 2953, 2856, 1694, 1422, 1257, 1151, 
1106, 1037, 916, 837, 777. MS (ES+): m/z 406 ([MNa]+). HRMS (ES+. [MNa]+): Calcd for C20H37NO4Si 384.2570 
Found 384.2575. 
 
(2S*,5S*,7R*,8aR*)-14: Rf = 0.86 (AcOEt). 
1H NMR (CDCl3, 300 MHz): δH 0.04 (3H, s, SiMe); 0.06 (3H, s, SiMe); 
0.89 (9H, s, SitertBu); 1.1 (1H, ddd, J = 11.7, 11.7, 11.7 Hz, H8ax); 1.27 (1H, m, H1); 1.5 (1H, ddd, J = 11.8, 11.8, 6.9 
Hz, H6ax); 2.07-2.28 (3H, m, CH2 CH=CH2 H8(eq) H6eq); 2.33 (1H, m, H1); 2.5 (1H, dddd, J = 9.9, 9.9, 9.9, 3.9 Hz, H2); 
2.65 (1H, ddd, J = 14.1, 5.3, 5.3 Hz, CH2 CH=CH2); 3.36 (3H, s, OMe); 3.64 (3H, m, H8a CH2 CH=CH2); 4.08 (1H, 
dddd, J = 11.2, 11.2, 4.0, 4.0 Hz, H7ax); 4.28 (1H, ddd, J = 5.8, 5.8, 5.8 Hz, H5eq); 4.68 (2H, bs, OCH2O); 5.06 (2H, m, 
CH2=CH); 5.77 (1H, dddd, J = 17.0, 10.1, 6.9, 6.9 Hz, CH2=CH). 
13C NMR (CDCl3, 100 MHz) C -5.6 (2SiMe); 18.1 
(SiC(CH3)3); 25.8 (SiC(CH3)3); 32.1 (C6); 32.9 (C1); 35.4 (CH2 CH=CH2); 40.2 (C8); 41.3 (C2); 49.1 (C5); 52.4 (C8a); 
55.2 (OMe); 63.9 (CH2O); 70.6 (C7); 94.8 (OCH2O); 116.7 (CH2=CH); 135.7 (CH2=CH); 174.5 (C3). IR (NaCl disc, 
cm-1): max = 2930, 1691, 1419, 1255, 1104, 1042, 840.. MS (ES
+): m/z = 384 ([MH]+), 406 ([MNa]+). HRMS (ES+. 
[MNa]+): Calcd for C20H37NO4Si 406.2390 Found 406.2386. 
 (2S*,5S*,7S*,8aR*)-2-allyl-7-benzyloxy-3-oxo-octahydro-indolizin-5-carboxylic acid 18 
To alcohol 16a (757 mg; 2.4 mmol) dissolved in 22 mL in acetone was added dropwise Jones reagent 2.67 M (1.1 mL; 
2.9 mmol; 1.2 equiv) at 0 °C. Stirring was continued for 40 min. 10 mL of isopropanol was added, the mixture was 
stirred for 20 min at 0 °C. After addition of 0.5 mL of water and 5 mL of 1 M HCl, the mixture was extracted twice 
with 100 mL of dichloromethane. The organic phase was dried (MgSO4) and the solvent removed in vacuo. The 
residue was purified by flash-chromatography on silica gel (AcOEt/MeOH/AcOH: 96/2/2) and the carboxylic acid 23 
was isolated as a beige solid (67%; 530 mg). 
Rf = 0.27 (AcOEt/MeOH/AcOH: 96/2/2). mp: 146 °C. 
1H NMR  (CDCl3, 400 MHz) δH (ppm): 1.18 (1H, ddd, J = 11.7, 
11.7, 11.7 Hz, H8ax); 1.36 (1H, m, H1); 1.63 (1H, ddd, J = 12.1, 12.1, 6.7 Hz, H6); 2.18 (1H, m, CH2CH=CH2); 2.27-
2.4 (2H, m, H1 H8); 2.58-2.69 (3H, m, H6, H2, CH2CH=CH2); 3.57 (1H, m, H7); 3.72 (1H, m, H8a); 4.54 (1H, d, J =9.1 
Hz, CH2Ph); 4.59 (1H, d, J =9.1 Hz, CH2Ph); 4.91 (1H, bd, J = 6.2 Hz, H5); 5.03-5.13 (2H, m, CH2=CH); 5.75 (1H, 
dddd, J= 16.9, 10.1, 6.8, 6.8 Hz, CH2=CH); 7.31 (5H, m, Ar). 
13C NMR (75 MHz, CDCl3) C 31.9 (C6); 32.4 (C1); 
35.0 (CH2CH=CH2); 39.2 (C8); 41.4 (C2); 50.5 (C5); 52.4 (C8a); 70.6 (CH2Ph); 72.7 (C7); 117.3 (CH2=CH); 127.7; 
127.9; 128.6 (2CAr CAr 2CAr); 135.2 (CH2=CH); 138.1 (CArquat); 173.1 (COOH); 176.4 (C3). MS (ES
+): m/z 352 
([MNa]+). 
(2S)-2-[(2S*,5S*,7S*,8aR*)-(2-allyl-7-benzyloxy-3-oxo-octahydro-indolizin-5-carbonyl)-amino]succinic acid ditertbutyl 
ester 19 
To carboxylic acid 18 (55 mg ; 0.167 mmol) dissolved in 1.5 mL of anhydrous dichloromethane was added 
N-methylmorpholine (NMM) (20 µL, 0.18 mmol, 1.1equiv) at -10 °C under argon, the mixture was stirred for 30 min 
at the same temperature. Isobutyl chloroformiate (23 µL, 0.18 mmol, 1.1 equiv) was added dropwise and stirring was 
continued for 1 h at -10 °C. The amino acid (51 mg, 0.18 mmol, 1.1 equiv) was dissolved in 1.5 mL of anhydrous 
dichloromethane under argon, NMM (40 µL, 0.36 mmol, 2.2 equiv) was added at 0 °C. This solution was stirred for 30 
min and added via a syringe to the mixed anhydride solution. Stirring was continued for 20 h at rt. The residue was 
taken off with 10 mL of ethyl acetate, washed with 5 mL of 10% Na2CO3 solution, 5 mL of 10% KHSO4 solution and 5 
mL of brine. The organic phase was dried over Na2SO4 and the solvent removed in vacuo.. The residue was purified by 
flash-chromatography on silica gel (AcOEt/cyclohexane: 25/75 to 70/30) and the compound was isolated as a white 
foam (88%, 65 mg). 
2 diastereoisomers Rf = 0.53 (AcOEt/cyclohexane: 40/60). 
1H NMR  (CDCl3, 400 MHz) δH (ppm): 1.16/1.17 (1H, ddd, 
J = 11.8, 11.8, 11.8 Hz, H8ax); 1.23-1.52 (20H, m, H1, H6, 2C(CH3)3); 2.11-2.5 (3H, m, H1, CH2CH=CH2, H8); 2.51-
2.9 (5H, m, CH2CH=CH2, CH2CO, H2, H6); 3.58-3.89 (2H, m, H7 H8a); 4.51-4.67 (3H, m, CH2Ph, NHCHCO); 4.85 
(1H, bd, J = 6.2 Hz, H5); 5.02-5.14 (2H, m, CH2=CH); 5.67-5.84 (1H, m, CH2=CH); 6.96/7.20 (1H, d/d, J = 8.0/8.6 
Hz, NH); 7.23-7.37 (5H, m, Ar). 13C NMR (75 MHz, CDCl3) C 27.9 and 28.0 (C(CH3)3); 30.8/31.2 32.2/32.4 35.1 
37.2/37.3 (C6, C1, CH2CH=CH2, CH2CO); 39.6/39.7 (C8); 40.9/41.0 (C2); 49.1/49.3 50.9 52.52.1 (C5, C8a, NHCHCO); 
70.5 (CH2Ph); 72.4 (C7); 81.6/81.9 and 82.2/82.4 (C(CH3)3); 117 (CH2=CH); 127.6; 128.3 (2CAr CAr 2CAr); 135.3 
(CH2=CH); 138.1 (CArquat); 169.2/169.3 169.5/169.5 169.9/170 175.6/175.7 (3CO, C3). HRMS (ES
+, [MNa]+): Calcd 
for C31H44N2O7 579.3046 Found 579.3019. 
3-[(2S*,5S*,7S*,8aR*)-(2-allyl-7-benzyloxy-3-oxo-octahydro-indolizin-5-carbonyl)-amino]propionic acid tertbutyl 
ester 20 
The same experimental procedure as described for peptide coupling was applied to carboxylic acid 18 (136 mg; 0.41 
mmol) using NMM (50 µL, 0.45 mmol, 1.1equiv), isobutyl chloroformiate (60 µL, 0.45 mmol, 1.1 equiv). Stirring was 
maintained 20 h after addition of amino acid (82 mg, 0.45 mmol, 1.1 equiv) and NMM (100 µL, 0.9 mmol, 2.2 equiv). 
Flash chromatography on silica gel (AcOEt/cyclohexane: 50/50 to 70/30) allowed the isolation of a colorless oil (83%, 
154 mg). 
Rf = 0.45 (AcOEt/cyclohexane: 60/40). 
1H NMR  (CDCl3, 400 MHz) δH (ppm): 1.17 (1H, ddd, J = 11.8, 11.8, 11.8 Hz, 
H8ax); 1.2-1.5 (11H, m, H1, H6, 2C(CH3)3); 2.18 (1H, m, H1); 2.29 (1H, bd, J = 12 Hz, H8); 2.35 (1H, m, 
CH2CH=CH2); 2.41 (2H, t, J = 6 Hz, NHCH2CH2CO); 2.52-2.7 (3H, m, H2, H6, CH2CH=CH2); 3.32-3.52 (2H, m, 
NHCH2CH2CO); 3.57 (1H, m, H8a); 3.9 (1H, dddd, J = 11, 11, 4.5, 4.5 Hz, H7); 4.57 (1H, d, J = 11.6 Hz, CH2Ph); 
4.63 (1H, d, J = 11.6 Hz, CH2Ph); 4.78 (1H, d, J = 5.9 Hz, H5); 5.02-5.12 (2H, m, CH2=CH); 5.77 (1H, dddd,, J = 15, 
12, 5.9, 5.9 Hz, CH2=CH); 6.65 (1H, bs, NH); 7.25-7.4 (5H, m, Ar). 
13C NMR (75 MHz, CDCl3) C 28.1 (C(CH3)3); 
30.9 (C6); 32.3 (C1); 35.1 (CH2CH=CH2, NHCH2CH2CO); 39.5 (C8); 41.1 (C2); 50.9 (C5); 52.1 (C8a); 70.5 (CH2Ph); 
72.4 (C7); 81.1 (C(CH3)3); 117.1 (CH2=CH); 127.6; 128.4 (2CAr CAr 2CAr); 135.2 (CH2=CH); 138.5 (CArquat); 169.9 
171.4 176.4 (2CO C3). IR (NaCl disc, cm
-1): max = 3307, 2929, 1727, 1682, 1427, 1278, 1156, 737. MS (ES
+): m/z 479 
([MNa]+). 
(S)-2-[[(2S*,5S*,7S*,8aR*)-(7-benzyloxy-2-(3-hydroxy-propyl)-3-oxo-octahydro-indolizin-5-carbonyl]-amino] succinic 
acid ditertbutyl ester 21 
The same experimental procedure as described for hydroboration was applied to alkene 19 (81 mg; 0.14 mmol) using a 
0.5 M solution of 9-BBN (1.5 mL; 0.73 mmol; 5 equiv). Stirring was maintained 15 h after addition of sodium acetate 
5 M (570 µL, 2.8 mmol, 20 equiv) and a 30 % H2O2 solution (0.160 mL; 22 equiv). Flash chromatography on silica gel 
(AcOEt/cyclohexane: 50/50 to 90/10) allowed the isolation of a yellow oil (68%, 57 mg). 
2 diastereoisomers Rf = 0.16 (AcOEt/cyclohexane: 90/10). 
1H NMR  (CDCl3, 400 MHz) δH (ppm): 1.13/1.15 (1H, 
ddd/ddd, J = 11.7, 11.7, 11.7 Hz, H8); 1.3-1.98 (23H, m, H6, 2C(CH3)3, CH2CH2CH2OH); 2.27 (1H, m, H8); 2.32-2.87 
(5H, m, H1, CH2CO, H2, H6); 3.6-3.66 (3H, m, CH2OH, H8a); 3.72-3.82 (1H, m, H7); 4.5-4.64 (3H, m, CH2Ph, 
NHCHCO); 4.79/4.85 (1H, m, H5); 6.74/6.82 (1H, d/d, J = 8.0/8.6 Hz, NH); 7.25-7.35 (5H, m, Ar). 
13C NMR (75 
MHz, CDCl3) C 20.2/27.1 (CH2); 28.0 and 28.1 (C(CH3)3); 30.3 31.0 31.4 36.4 37.3 (CH2); 39.6/39.7 (C8); 41.2/41.3 
(C2); 49.1/49.4 (NHCHCO); 51.0 (C5); 52.1/52.3 (C8a); 62.2 (CH2OH); 70.6 (CH2Ph); 72.4/72.5 (C7); 81.7 82.0 and 
82.3/82.5 (C(CH3)3); 127.6; 128.5 (2CAr CAr 2CAr); 138.1 (CArquat); 169.4/169.6 170.1 170.2 176.7/176.8 (3CO, C3). 
3-[[(2S*,5S*,7S*,8aR*)-7-benzyloxy-2-(3-hydroxy-propyl)-3-oxo-octahydro-indolizin-5-carbonyl]-amino]propionic 
acid tertbutyl ester 22 
The same experimental procedure as described for hydroboration was applied to alkene 20 (106 mg; 0.23 mmol) using 
a 0.4 M solution of 9-BBN in hexane (1.5 mL; 0.58 mmol; 2.5 equiv). Stirring was maintained 16 h after addition of 
sodium acetate 5 M (550 µL, 2.76 mmol, 12 equiv) and a 30 % H2O2 solution (0.280 mL; 12 equiv). Flash 
chromatography on silica gel (AcOEt/MeOH: 100 to 99/1) allowed the isolation of a yellow oil (71%, 74 mg). 
Rf = 0.3 (AcOEt/MeOH: 95/5). 
1H NMR  (CDCl3, 300 MHz) δH (ppm): 1.14 (1H, ddd, J = 11.8, 11.8, 11.8 Hz, H8ax); 
1.22-1.52 (12H, m, H1, H6,CH2CH2CH2OH, 2C(CH3)3); 1.6 (2H, q, J = 11.8 Hz, CH2CH2CH2OH); 1.93 (1H, m, 
CH2CH2-CH2OH); 2.27 (1H, bd, J = 12 Hz, H8); 2.39 (2H, t, J = 6 Hz, NHCH2CH2CO); 2.41-2.54 (2H, m, H2, H1); 
2.6 (1H, bd, J = 12 Hz, H6); 3.04 (1H, s, OH); 3.2-3.5 (2H, m, NHCH2CH2CO); 3.63 (1H, m, H8a); 3.63 (2H, t, J = 6.1 
Hz, CH2OH); 3.88 (1H, dddd, J = 12, 12, 4.5, 4.5 Hz, H7); 4.55 (1H, d, J = 11.7 Hz, CH2Ph); 4.62 (1H, d, J = 11.7 Hz, 
CH2Ph); 4.74 (1H, d, J = 5.9 Hz, H5); 6.79 (1H, t, J = 6 Hz, NH); 7.2-7.45 (5H, m, Ar). 
13C NMR (75 MHz, CDCl3) C 
27.2 (CH2CH2CH2OH); 28.1 (C(CH3)3); 29.7 (CH2CH2CH2OH); 31.1 (C6); 33.3 (C1); 35.1 (NHCH2CH2CO); 39.5 
(C8); 41.3 (C2); 50.9 (C5); 52.3 (C8a); 62.1 (CH2OH); 70.5 (CH2Ph); 72.3 (C7); 81.1 (C(CH3)3); 127.6; 128.4 (2CAr CAr 
2CAr); 138.4 (CArquat); 169.9 171.4 176.4 (2CO C3). 
guanidine carbamate 23 
Alcohol 21 (60 mg, 0.1 mmol) and 1,3-bis(tert-butoxycarbonyl) guanidine (53 mg, 0.2 mmol, 2 equiv) was dried under 
vacuo, dissolved in 2.5 mL of anhydrous toluene under argon. Tributylphosphine (50 μL, 0.2 mmol, 2 equiv) was 
added to the solution at rt, then dipiperidinazodicarboxylate (ADDP) (52 mg, 0.2 mmol, 2 equiv) at 0 °C. The mixture 
was refluxed for 4 h. After removal of the toluene under vacuo, the residue was purified by f lash chromatography on 
silica gel (Et2O/cyclohexane/MeOH: 85/14/1) allowed the isolation of 23 as a colorlessoil (46 mg, 60%). 
2 diastereoisomers Rf = 0.14 (Et2O/cyclohexane/MeOH: 85/14/1). 
1H NMR (CDCl3, 400 MHz) δH (ppm): 1.01-1.4 
(31H, m, H8, H6, 3C(CH3)3, CH2CH2CH2OH); 1.5-1.7 (2H, m, CH2CH2CH2OH); 1.5-1.7 (1H, m, CH2CH2CH2OH); 
2.1-2.4 (2H, m, H1, H8); 2.4-2.88 (4H, m, CH2CO, H2, H6); 3.48-3.62 (1H, m, H8a); 3.62-3.78 (1H, m, H7); 4.03 (2H, 
bs, CH2OH); 4.43-4.59 (3H, m, CH2Ph, NHCHCO); 4.76 (1H, d, J = 11.7 Hz, H5); 7.21/7.26 (1H, d/d, J = 8.1/8.6 Hz, 
NH); 7.15-7.29 (5H, m, Ar). 13C NMR (75 MHz, CDCl3) C 26.7 27.6/27.7 (CH2CH2CH2OH); 28.0 and 28.1 
(3C(CH3)3); 29.8/30.4 30.9/31.3 33.3/33.4 (C6, C1, CH2CO); 39.6/39.8 (C8); 41.2/41.3 (C2); 49.1/49.4 50.9/51.0 
52.0/52.2 (C5, NHCHCO, C8a); 65.5 (CH2OH); 70.9 (CH2Ph); 72.4/72.5 (C7); 81.7 81.9 82.2 and 82.5 (C(CH3)3); 
127.7 127.8 128.5 (2CAr CAr 2CAr); 138.6 (CArquat); 158.5 169.4 169.7 169.8 170 170.1 170.2 176/176.2 (C=N 5CO C3). 
MS (ES+): m/z 760 ([MH]+). HRMS (ES+, [MNa]+): Calcd for C38H57N5O11 782.3952 Found 782.3969. 
peptidomimetic 24 
TFA (0.5 mL; 6.5 mmol) was added to a cooled (0 °C) solution of compound 23 (46 mg; 0.06 mmol) dissolved in 
CH2Cl2 (2 mL) with a droplet of water. The mixture was stirred at rt for 4h. The mixture was concentrated in vacuo 
after addition of toluene (2 mL). Two more additions and evaporations of toluene were done and finaly the residue was 
taken in ether (1 mL) and extracted with water (3 times). The aqueous phase was lyophilysed to leave 24 as a foam in a 
quantitative yield (33 mg). 
2 diastereoisomers mp: 60 °C. 1H NMR (D2O, 400 MHz) δH (ppm): 1.07 (1H, ddd, J = 11.7, 11.7, 11.7 Hz, H8); 1.32 
(2H, m, CH2CH2CH2O, H1); 1.52 (1H, m, H6); 1.65 (2H, m, CH2CH2CH2O); 1.75 (1H, m, CH2CH2CH2O); 2.1 (1H, 
bd, J = 10.3 Hz, H8); 2.24 (1H, m, H6); 2.4 (1H, m, H1); 2.59 (1H, m, H2); 2.7-2.88 (2H, m, CH2COOH); 3.65-3.8 (2H, 
m, H7 H8a); 4.12 (2H, t, J = 6.0 Hz, CH2OCO); 4.48-4.70 (3H, m, NHCHCO, CH2Ph); 4.70 (1H, m, H5); 7.29 (5H, m, 
Ar). 13C NMR (100 MHz, MeOD) C 25.6 (CH2CH2CH2OH); 26.6 (CH2CH2CH2OH); 32.6 et 32.7 (C1); 34.4 et 34.5 
(C6); 35.4 (CH2COOH); 41.0 (C8); 41.3 (C2); 48.9 (NHCHCO); 51 (C5); 52.7 et 52.9 (C8a); 64.2 (C7); 67.0 
(CH2OCO); 70.3 (CH2Ph); 127.5; 127.7; 128.1 and 128.3 (2CAr CAr 2CAr); 138.1 (CArquat); 153.0 and 155.4 (C=N 
OCONH); 170.7; 170.8; 172.6; 173; 173.1 and 177.2 (2NHCO 2 COOH C3). [MH]
+). HRMS (ES+, [MH]+): Calcd for 
C25H33N5O9 548.2357 Found 548.2339. 
3-[[(2S*,5S*,7S*,8aR*)-7-benzyloxy-2-(3-bis(tert-butyloxycarbonyl)guanidino-propyl)-3-oxo-octahydro-indolizin-5-
carbonyl]-amino]-propionic acid tertbutyl ester 25 
Alcohol 22 (76 mg, 0.16 mmol) and 1,3-bis(tert-butoxycarbonyl) guanidine (70 mg, 0.27 mmol, 2.1 equiv) was dried 
under vacuo, dissolved in 5 mL of anhydrous THF under argon. Triphenylphosphine (87 mg, 0.33 mmol, 2 equiv) was 
added to the solution at rt, then diethylazodicarboxylate (DEAD) (52 µL, 0.33 mmol, 2 equiv) at 0 °C. The mixture 
was stirred for 60 h. at rt. After addition of dichloromethane, the  solvent was removed in vacuo. The residue was 
purified by flash chromatography on silica gel (Et2O/cyclohexane: 90/10) to give a white foam (105 mg, 92%).  
Rf = 0.22 (Et2O/cyclohexane: 90/10). 
1H NMR  (CDCl3, 300 MHz) δH (ppm): 1.15 (1H, ddd, J = 11.7, 11.7, 11.7 Hz, 
H8); 1.18-1.4 (3H, m, H1, H6,CH2CH2CH2N); 1.44 (9H, s, C(CH3)3); 1.49 (9H, s, C(CH3)3); 1.55 (9H, s, C(CH3)3); 
1.65 (2H, m, CH2CH2CH2N); 1.94 (1H, m, CH2CH2CH2N); 2.28 (1H, bd, J = 11.6 Hz, H8); 2.39 (2H, t, J = 6 Hz, 
NHCH2CH2CO); 2.43-2.49 (2H, m, H2, H1); 2.63 (1H, bd, J = 12.7 Hz, H6); 3.34-3.49 (2H, m, NHCH2CH2CO); 3.56 
(1H, m, H8a); 3.7-4.05 (3H, m, H7, CH2N); 4.55 (1H, d, J = 11.8 Hz, CH2Ph); 4.63 (1H, d, J = 11.8 Hz, CH2Ph); 4.74 
(1H, d, J = 5.6 Hz, H5); 6.68 (1H, t, J = 5.9 Hz, NH); 7.3 (5H, m, Ar); 9.1-9.4 (2H, bs, NH2). 
13C NMR (75 MHz, 
CDCl3) C 26.2 (CH2CH2CH2N); 28.1 and 28.3 (3C(CH3)3, CH2CH2CH2N); 30.8 (C6); 33.3 (C1) 35.2 
(NHCH2CH2CO); 39.6 (C8); 41.1 (C2); 44.3 (CH2CH2CH2N); 50.9 (C5); 52.3 (C8a); 70.6 (CH2Ph); 72.4 (C7); 78.6 81.1 
and 83.7 (3C(CH3)3); 127.6; 128.3 (2CAr CAr 2CAr); 138.5 (CArquat); 155 160.5 and 163.8 (C=N CON); 169.9 171.3 
176.4 (2CO C3). IR (NaCl disc, cm
 1): max = 3382, 2977, 1715, 1608, 1514, 1368, 1251, 1152, 737. MS (ES
+): m/z 
739([MNa]+). 
3-[[(2S*,5S*,7S*,8aR*)-7-benzyloxy-2-(3-guanidino-propyl)-3-oxo-octahydro-indolizin-5-carbonyl]-amino]-propionic 
acid 26 
The same protocol for deprotection with TFA was applied to compound 25 (43 mg; 0.06 mmol). Guanidyl compound 
was obtained as foam in a quantitative yield (28 mg). 
1H NMR  (D2O, 300 MHz) δH (ppm): 1.04 (1H, ddd, J = 11.7, 11.7, 11.7 Hz, H8); 1.28 (2H, m, H1, CH2CH2CH2NH); 
1.48 (3H, m, CH2CH2CH2NH H6); 1.7 (1H, m, CH2CH2CH2NH); 2.21 (1H, bd, J = 11.7 Hz, H8); 2.27-2.48 (4H, m, 
NHCH2CH2CO H6 H1); 2.55 (1H, m, H2); 3.06 (2H, t, J = 6.0 Hz, CH2CH2CH2NH); 3.31 (2H, t, J = 5.7 Hz, 
NHCH2CH2CO); 3.51 (1H, m, H7); 3.65 (1H, m, H8a); 4.47 (1H, s, CH2Ph); 4.62 (1H, d, J = 5.6 Hz, H5); 7.28 (5H, m, 
Ar). 13C NMR (75 MHz, D2O) C 25.2 (CH2CH2CH2NH); 27.2 (CH2CH2CH2NH); 31.6 (C6); 31.9 (C1); 33.4 
(NHCH2CH2CO); 35.2 (NHCH2CH2CO); 38.2 (C8); 40.8 (CH2CH2CH2NH); 41.0 (C2); 51.6 (C8a); 53.3 (C5); 70.2 
(CH2Ph); 71.8 (C7); 128.3; 128.5 and 128.7 (2CAr CAr 2CAr); 137.1 (CArquat); 156.6 (C=N); 171.4 175.8 178.6 (2CO 
C3). MS (ES
+): m/z 460([MH]+). HRMS (ES+, [MH]+): Calcd for C23H33N5O5 460.2560 Found 460.2552. 
3-[(2S*,5S*,7S*,8aR*)-[2-(3-guanidino-propyl)-7-hydroxy-3-oxo-octahydro-indolizin-5-carbonyl]-amino]-propionic 
acid 27 
To benzyl ether 25 (45 mg, 0.063 mmol) dissolved in 7 mL of methanol was added 35 mg of palladium on activated 
carbon (10% Pd). The mixture was put under hydrogen, stirred 24 h. After filtration on celite,washing with ethyl 
acetate, the solvants were removed under vacuo. The residue was purified by f lash chromatography on silica gel (Ethyl 
acetate) to give a colorless oil (28 mg, 71%). 
Rf = 0.36 (AcOEt/MeOH: 99/1). 
1H NMR  (CDCl3, 300 MHz) δH (ppm): 1.14 (1H, ddd, J = 11.7, 11.7, 11.7 Hz, H8); 
1.23-1.38 (2H, m, H1 CH2CH2CH2N); 1.38-1.45 (28H, s, H6 3C(CH3)3); 1.59-1.73 (2H, m, CH2CH2CH2N); 1.95 (1H, 
m, CH2CH2CH2N); 2.21 (1H, dm, J = 12 Hz, H8); 2.4 (2H, t, J = 6.2 Hz, NHCH2CH2CO); 2.43-2.63 (3H, m, H2 H1 
H6); 3.42 (2H, m, NHCH2CH2CO); 3.59 (1H, m, H8a); 3.8 (1H, m, CH2N); 4.01 (1H, m, CH2N); 4.13 (1H, m, H7); 4.73 
(1H, d, J = 5.7 Hz, H5); 6.74 (1H, t, J = 4.5 Hz, NH); 9.26 (2H, bs, NH2). 
13C NMR (75 MHz, CDCl3) C 26.2 
(CH2CH2CH2N); 28.1 and 28.3 (3C(CH3)3); 33.3 33.9 35.1 (NHCH2CH2CO, C8, C6, C1); 41.1 (C2); 41.7 44.3 
(NHCH2CH2CO CH2CH2CH2N); 50.9 52.3 (C5 C8a); 65.0 (C7); 78.6 81.1 and 83.7 (3C(CH3)3); 127.6; 128.3 (2CAr CAr 
2CAr); 138.5 (CArquat); 155 (C=N); 160.5 and 163.8 (C=N, CON); 169.9 171.4 176.5 (2CO C3). IR (NaCl disc, cm
 1): 
max = 3383, 2978, 1715, 1608, 1515, 1251, 1151, 1101, 736. MS (ES
+): m/z 626 ([MH]+. 
The same protocol for deprotection with TFA was applied to compound described above (28 mg; 0.045  mmol). 
Guanidyl compound 27 was obtained as an oil in a quantitative yield (17 mg). 
1H NMR  (D2O, 400 MHz) δH (ppm): 1.14 (1H, ddd, J = 11.7, 11.7, 11.7 Hz, H8); 1.24-1.35 (2H, m, H1 
CH2CH2CH2N); 1.45-1.55 (2H, m, H6 CH2CH2CH2N); 1.69 (1H, m, CH2CH2CH2N); 2.12 (1H, dm, J = 12.1 Hz, H8); 
2.21 (1H, dm, J = 13.2 Hz, H6); 2.39 (1H, ddd, J = 12.6, 8.9, 7.1 Hz, H1); 2.47 (1H, t, J = 6.4 Hz, NHCH2CH2CO); 
2.58 (1H, dddd, J = 9.4, 9.4, 9.4, 4.2 Hz, H2); 3.08 (2H, t, J = 6.8 Hz, CH2CH2CH2N); 3.35 (2H, t, J = 6.4 Hz, 
NHCH2CH2CO); 3.65-3.75 (2H, m, H7 H8a); 4.62 (1H, d, J = 5.6 Hz, H5). 
13C NMR (75 MHz, D2O) C 25.2 
(CH2CH2CH2N); 27.3 (CH2CH2CH2N); 31.5 (C1); 33.5 (NHCH2CH2CO); 34.1 (C6); 35.3 (NHCH2CH2CO); 40.5 (C8); 
40.8 (CH2CH2CH2N); 41.0 (C2); 51.2 (C5); 53.3 C8a); 64.3 (C7); 156.7 (C=N); 171.7 176.1 178.8 (2CO C3). MS (ES
+): 
m/z 370 ([MH]+ 392 ([MNa]+. HRMS (ES+, [MNa]+): Calcd for C16H27N5O5 370.2090 Found 370.2078. 
(2R*,5S*,7S*,8aR*)-2-allyl-7-methoxymethoxy-3-oxo-octahydro-indolizin-5-carboxylic acid 28 
To alcohol 17b (105 mg; 0.39 mmol) dissolved in 3.5 mL of acetone was added dropwise Jones reagent 2.67 M (220 
µL; 0.58 mmol; 1.5 equiv) at 0 °C. Stirring was continued for 30 min. 3 mL of isopropanol was added, the mixture was 
stirred for 10 min at 0 °C. After addition of 1 mL of water and 1 mL of a saturated solution of KHSO4, the mixture was 
extracted twice with 100 mL of dichloromethane. The organic phase was dried (MgSO4) and the solvent removed in 
vacuo. The residue was purified by flash-chromatography on silica gel (AcOEt/MeOH/AcOH: 97/1/2) and the 
carboxylic acid 28 was isolated as a white foam (54%; 60 mg). 
Rf = 0.35 (AcOEt/MeOH/AcOH: 97/1/2).
 1H (CDCl3, 300 MHz): δH 1.19 (1H, ddd, J = 11.8, 11.8, 11.8 Hz, H8ax); 1.58 
(1H, ddd, J = 12.9, 12.9, 6.8 Hz, H6); 1.79 (1H, ddd, J = 13.0, 9.2, 7.7 Hz, H1); 2.05 (1H, m, H1); 2.25 (2H, m, H8 
CH2CH=CH2); 2.55 (3H, m, H2 H6 CH2CH=CH2 ); 3.38 (3H, s, CH2OMe); 3.70 (1H, dddd, J=11.4, 11.4, 3.9, 3.9 Hz, 
H7ax); 3.82 (1H, dddd, J=11.6, 8.0, 8.0, 3.8 Hz, H8a); 4.69 (2H,s, OCH2O); 4.95 (1H, d, J = 5.4 Hz, H5eq); 5.06 (1H, bd, 
J = 17.1 Hz CH2=CH); 5.09 (1H, dd, J = 7.0, 1.3 Hz, CH2=CH); 5.8 (1H, dddd, J = 17.1, 10.1, 7.0, 7.0 Hz, CH2=CH). 
13C NMR (75 MHz, CDCl3) C 30.4 (C1); 32.3 (C6); 35.4 (CH2-CH=CH2); 39.4 (C8); 41.0 (C2); 50.0 (C5); 52.3 (C8a); 
55.4 (CH2OMe); 70.8 (C7); 94.7 (OCH2O); 117.4 (CH2=CH); 135.3 (CH2=CH); 172.3 (COOH); 176.4 (C3). IR (NaCl 
disc, cm-1): max = 2936, 2368, 1735, 1651, 1451, 1211, 1112, 1039. MS (ES
+): m/z 306 ([MNa]+). HRMS (ES+. 
[MNa]+): Calcd for C14H21NO5  306.1317 Found: 306.1306. 
 
(2S)-2-[(2R*,5S*,7S*,8aR*)-(2-allyl-7-methoxymethoxy-3-oxo-octahydro-indolizin-5-carbonyl)-amino] pentanedioic 
acid tertbutyl ester 29 
The same experimental procedure as described for peptide coupling was applied to carboxylic acid 28 (88 mg; 0.31 
mmol) using NMM (37 µL, 0.34 mmol, 1.1equiv), isobutyl chloroformiate (44 µL, 0.34 mmol, 1.1 equiv). Stirring was 
maintained 20 h after addition of amino acid (100 mg, 0.34 mmol, 1.1 equiv) and NMM (74 µL, 0.68 mmol, 2.2 
equiv). Flash chromatography on silica gel (AcOEt/cyclohexane: 80/20) allowed the isolation of a colorless oil (90%, 
146 mg). 
2 diastereoisoers. Rf = 0.6 (AcOEt/cyclohexane: 90/10).
 1H (CDCl3, 300 MHz): δH 1.12 (1H, ddd, J = 10.8, 10.8, 10.8 
Hz, H8ax); 1.39 (19H, m, 2C(CH3)3, H6); 1.72-1.87 (2H, m, NHCHCH2CH2CO, H1); 1.98-2.07 (1H, m, 
NHCHCH2CH2CO, H1); 2.1-2.3 (4H, m, NHCHCH2CH2CO H8 CH2CH=CH2); 2.4-2.6 (3H, m, H2 H6 CH2CH=CH2 ); 
3.29 (3H, s, CH2OMe); 3.66 (1H, m, H8a); 3.82/3.92 (1H, dddd/dddd, J = 11.3, 11.3, 3.9, 3.9 /11.2, 11.2, 3.9, 3.9 Hz, 
H7ax); 4.33 (1H, m, NHCHCH2CH2CO); 4.63 (2H, m, OCH2O); 4.77/4.80 (1H, d/d,, J = 5.7 /6.2 Hz, H5eq); 5.06 (1H, 
bd, J = 17.1 Hz CH2=CH); 5.04 (1H, m, CH2=CH); 5.73 (1H, m, CH2=CH); 6.66/6.73 (1H, d/d, J = 7.7 /8.0 Hz, NH). 
13C NMR (75 MHz, CDCl3) C 27.3/27.4 (2C(CH3)3); 30.2 (C1 NHCHCH2CH2CO); 31.2 (C6); 31.5 
(NHCHCH2CH2CO); 35.4 (CH2-CH=CH2); 39.3 (C8); 40.4 (C2); 50.0 50.9 52.2 (C5, C8a, NHCHCH2CH2CO); 55.3 
(CH2OMe); 70.8 (C7); 80.65 (C(CH3)3); 82.1/82.2 (C(CH3)3); 95.2 (OCH2O); 117.3:117.5 (CH2=CH); 135.0/035.3 
(CH2=CH); 169.6/169.7 170.4/170.6 171.8 (3CO); 176.4/176.4 (C3). MS (ES
+): m/z 547 ([MNa]+). 
(2S)-2-[[(2R*,5S*,7S*,8aR*)-2-(3-hydroxy-propyl)-7-methoxymethoxy-3-oxo-octahydro-indolizin-5-carbonyl]-amino] 
pentanedioic acid tertbutyl ester) 30 
The same experimental procedure as described for hydoboration was applied to 29 (139 mg; 0.27 mmol) using a 0.5 M 
solution of 9-BBN (1.6 mL; 0.81 mmol; 3 equiv). Stirring was maintained 15 h after addition of sodium acetate 5 M 
(0.57 mL, 2.84 mmmol, 10.5 equiv) and a 30 % H2O2 solution (0.33 mL; 12 equiv). Flash chromatography on silica gel 
(AcOEt/MeOH: 98/2 to 95/5) allowed the isolation of a colorless oil (65%, 93 mg). 
Rf = 0.15 (AcOEt/MeOH: 98/2).  1H (CDCl3, 300 MHz): δH 1.18 (1H, ddd, J = 11.2, 11.2, 11.2 Hz, H8); 1.3-1.72 (23H, 
m, 2C(CH3)3 H6 CH2CH2CH2OH); 1.78-1.99 (3H, m, NHCHCH2CH2CO, H1); 1.99-2.12 (1H, m, H1); 2.12-2.3 (3H, 
m, NHCHCH2CH2CO H8); 2.45-2.64 (2H, m, H2, H6); 3.35 (3H, s, CH2OMe); 3.62-3.78 (3H, m, CH2OH, H8a); 
3.89/3.99 (1H, dddd/dddd, J = 11.2, 11.2, 3.9, 3.9/11.2, 11.2, 4, 4 Hz, H7); 4.33-4.45 (1H, m, NHCHCH2CH2CO); 
4.67/4.68 (1H, d/d, J = 6.8/6.8, OCH2O); 4.72/4.73 (1H, d/d, J = 6.8/6.8, OCH2O); 4.83/4.86 (1H, d/d,, J = 6 /5.3 Hz, 
H5); 6.74/6.82 (1H, d/d, J = 8.1 /7.7 Hz, NH). 
13C NMR (75 MHz, CDCl3) C 25.7 27.4 27.7 (CH2); 28.0 (2C(CH3)3); 
30.1 30.2 31.5 (CH2); 31.1 (C6); 39.3/39.5 (C8); 40.5/40.6 (C2); 50.9 (C5 ); 52.3 (C8a NHCHCH2CH2CO); 55.4 
(CH2OMe); 62.3/62.5 (CH2OH); 70.9 (C7); 80.8/81.1 82.5 (C(CH3)3); 95.2:95.3 (OCH2O); 169.6/169.7 170.5/171 
172/172.2 (3CO); 177.1/177.3 (C3). IR (NaCl disc, cm
 1): max = 3313, 2934, 1730, 1536, 1453, 1369, 1257, 1154. MS 
(ES+): m/z 565 ([MNa]+). HRMS (ES+. [MNa]+): Calcd. for C27H46N2O9 565.3101 Found 565.3084. 
guanidine carbamate 31 
Alcohol 30 (67 mg, 0.127 mmol) and 1,3-bis(tert-butoxycarbonyl) guanidine (70 mg, 0.27 mmol, 2.1 equiv) was dried 
under vacuo, dissolved in 2.5 mL of anhydrous THF under argon. Tributylphosphine (63 μL, 0.25 mmol, 2 equiv) was 
added to the solution at rt, then dipiperidinazodicarboxylate (ADDP) (63 mg, 0.25 mmol, 2 equiv) at 0 °C. The mixture 
was refluxed 2 h. After addition of water and dichloromethane, the mixture was extracted. The organic phase was dried 
(MgSO4) and the solvent removed in vacuo. The residue was purified by flash chromatography on silica gel 
(Et2O/MeOH: 97/3) to give a white solid (40 mg, 43%).  
Rf = 0.1 (Et2O/MeOH: 98/2).
 1H (CDCl3, 400 MHz): δH 1.18 (1H, ddd, J = 11.7, 11.7, 11.7 Hz, H8); 1.27-1.48 (28H, 
m, 3C(CH3)3 H6); 1.5-1.63 (1H, m, CH2CH2CH2OH); 1.73-2.28 (10H, m, H8, NHCHCH2CH2CO CH2CH2CH2OH 
H1); 2.43-2.59 (2H, m, H2 H6); 3.33 (3H, s, CH2OMe); 3.64-3.76 (1H, m, H8a); 3.85/3.93 (1H, dddd/dddd, J = 11.2, 
11.2, 4.0, 4.0/11.2, 11.2, 4.0, 4.0 Hz, H7); 4.05-4.15 (2H, m, CH2OH); 4.32-4.43 (1H, m, NHCHCH2CH2CO); 
4.65/4.66 (1H, d/d, J = 6.8/6.8 Hz, OCH2O); 4.69/4.695 (1H, d/d, J = 6.8/6.8, OCH2O); 4.81/4.84 (1H, d/d,, J = 6 /5.8 
Hz, H5); 6.74/6.82 (1H, d/d, J = 8.0 /7.6 Hz, NH). 
13C NMR (75 MHz, CDCl3) C 26.5 26.6 27.3 27.4 28.0 (3C(CH3)3); 
29.6 31.2 31.5 (CH2); 39.0/39.3 (C8); 40.3 (C2); 50.9 (C5); 52/52.1 52.2/52.4 (C8a NHCHCH2CH2CO); 55.3 
(CH2OMe); 64.9 (CH2OH); 70.9 (C7); 80.8 82.2 82.3 82.7 (C(CH3)3); 95.2 (OCH2O); 158.7 169.7 169.8 170.7 172.0 
(5CO C=N); 176.4/176.8 (C3). IR (NaCl disc, cm
 1): max = 3403, 2979, 1730, 1554, 1370, 1256, 1156, 1042, 733. MS 
(ES+): m/z 750 ([MNa]+). HRMS (ES+. [MNa]+): Calcd. for C34H57N5O12 750.3901 Found 750.3885. 
peptidomimetic 32 
The same protocol for deprotection with TFA was applied to compound 31 (29 mg; 0.04 mmol). Guanidyl compound 
was obtained as a foam in a quantitative yield (19 mg). 
1H NMR (D2O, 400 MHz) δH (ppm): 1.11 (1H, ddd,
 J = 11.7, 11.7, 11.7 Hz, H8 ); 1.4-1.58 (2H, m, H6, CH2CH2CH2O); 
1.58-1.7 (3H, m, CH2CH2CH2O); 1.72-1.9 (2H, m, NHCHCH2CH2COOH, H1); 1.9-2.17 (5H, m, 
NHCHCH2CH2COOH H8 H1); 2.27 (1H, m, H6); 2.53 (1H, m, H2); 3.78-3.9 (2H, m, H7 H8a); 4.03 (1H, m, 
NHCHCH2CH2COOH); 4.11 (2H, bs, CH2CH2CH2O); 4.68 (1H, m, H4). HRMS (ES
+, [MNa]+): Calcd for C19H29N5O9 
494.1863 Found 494.1860. 
(2S)-2-[[(2R*,5S*,7S*,8aR*)-2-(3-bis(tert-butyloxycarbonyl)-guanidino-propyl)-7-methoxymethoxy-3-oxo-octahydro-
indolizin-5-carbonyl]-amino] pentanedioic acid tertbutyl ester) 33 
The same experimental procedure as described for 25 above was applied to 30 (33 mg; 0.062 mmol) using and 1,3-
bis(tert-butoxycarbonyl) guanidine (39 mg, 0.15 mmol, 2 equiv), triphenylphosphine (40 mg, 0.15 mmol, 2 equiv) and 
diethylazodicarboxylate (DEAD) (24 µL, 0.15 mmol, 2 equiv). Stirring was continued for 3 days. Flash 
chromatography on silica gel (Et2O/cyclohexane: 70/30 to 100/0) allowed the isolation of 33 as a colorless oil (29 mg, 
60%) (2 diastereoisomers). 
Rf = 0.45 (Et2O).
 1H (CDCl3, 400 MHz): δH 1.21 (1H, ddd, J = 11.7, 11.7, 11.7 Hz, H8); 1.35-1.6 (37H, m, 4C(CH3)3 
H6); 1.62-2.12 (8H, m, CH2CH2CH2NH H8 NHCHCH2CH2CO H1); 2.15-2.3 (3H, m, NHCHCH2CH2CO H8); 2.47-
2.63 (2H, m, H6 H2); 3.36 (3H, s, CH2OMe); 3.7-4.06 (4H, m, H8a CH2CH2CH2NH H7); 4.09 (1H, m, 
NHCHCH2CH2CO); 4.67 (1H, d, J = 6.8 Hz, OCH2O); 4.71 (1H, d, J = 6.8, OCH2O); 4.74 (1H, d, J = 5.4 Hz, H5); 
6.72 (1H, d, J = 7.6 Hz, NH); 9.26 (2H, bs, NH2). 
13C NMR (75 MHz, CDCl3) C 26.3 26.5 27.4 (CH2CH2CH2NH 
NHCHCH2CH2CO); 28.1 28.3 (4C(CH3)3); 30.8 31.5 31.6 (CH2CH2CH2NH NHCHCH2CH2CO C6 C1); 38.9/39.2 
(C8); 40.1 (C2); 44.2 (CH2CH2CH2NH); 51 52 52.1 52.3 55.4 (C8a C5 NHCHCH2CH2CO CH2OMe); 64; 70.9 71.0(C7); 
78.6 80.8 82.3 83.7 (4C(CH3)3); 95.2 (OCH2O); 155.0 160.5 and 163.8 (C=N N-CO); 169.8 170.5 170.7 172.0 176.9 
177.2 (4CO C3). IR (NaCl disc, cm
-1): max = 3382, 2977, 1715, 1609, 1513, 1368, 1251, 1152, 737. MS (ES
+): m/z 784 
([MH]+). 
(2S)-2-[[(2R*,5S*,7S*,8aR*)-2-(3-guanidino-propyl)-7-hydroxy-3-oxo-octahydro-indolizin-5-carbonyl]-amino] 
pentanedioic acid 34 
The same protocol for deprotection with TFA was applied to compound 33 (46 mg; 0.06 mmol). Guanidyl compound 
was obtained as a white solid in a quantitative yield (33 mg). 
mp: 60 °C.  1H (D2O, 400 MHz): δH 1.1 (1H, m, H8); 1.35-1.53 (5H, m, CH2CH2CH2NH H6); 1.77-1.98 (3H, m, 
NHCHCH2CH2CO H8); 1.98-2.15 (2H, m, H8); 2.21 (1H, m, H6); 2.31 (2H, bs, NHCHCH2CH2CO); 2.52 (1H, bs, 
H2); 3.06 (2H, t, J = 5.9 Hz, CH2CH2CH2NH); 3.71 (1H, m, H7); 3.79 (1H, m, H8a); 4.25 (1H, m, NHCHCH2CH2CO); 
4.63 (1H, m, H5). 
13C NMR (100 MHz, D2O) C 25.5 25.6 (CH2CH2CH2NH NHCHCH2CH2CO); 27.7 
(CH2CH2CH2NH); 30.1 30.3 (NHCHCH2CH2CO, C1); 34.0 (C6); 39.8 (C8); 40.8 (C2); 40.9 (CH2CH2CH2NH); 
51.0/51.1 (C5); 52.4 (NHCHCH2CH2CO); 53.7/53.9 (C8a); 64.6 (C7); 156.7 (C=N); 171.9 172.1 (CONH); 175.1 
(NHCHCOOH) 177.1 (COOH); 179.3 (C3). MS (ES
+): m/z 428 ([MH]+). HRMS (ES+, [MH]+): Calcd for C18H29N5O7 
428.2145 Found 428.2146. 
(5S*,7R*,8aR*)-7-benzyloxy-5-methyl-3-oxo-octahydro-indolizin-5-carboxylic acid ethyl ester 35 
To 12a (430 mg; 1.42 mmol) dissolved in 90 mL of anhydrous THF under argon at -78 °C, was added 23.3 mL (11.7 
mmol, 1.1 equiv) of KHMDS 0.5 M in toluene. After 30 min, methyl iodide (filtered on neutral aluminium oxide; 725 
μL, 11.65 mmol, 1.1 equiv) was added. Stirring was continued for 3h at -78°C, reaction was quenched with a satured 
solution of NH4Cl. The product was extrated twice with CH2Cl2. The organic phase was dried (MgSO4) and the solvent 
removed in vacuo. Flash chromatography on silica gel (AcOEt/cyclohexane: 50/50) allowed the isolation of 35 as a 
pale yellow oil (3.5 mg, 99%). 
Rf = 0.37 (AcOEt/cyclohexane: 70/30) 
1H NMR (CDCl3, 300 MHz): δH 1.12 (3H, t, J = 7.1 Hz; CH3CH2); 1.36 (1H, 
ddd, J = 13.5, 12.2, 2.6 Hz, H8ax); 1.50 (1H, dddd, J = 10.4, 10.4, 10.4, 10.4 Hz, H1); 1,56 (1H, dd, J = 14.4, 2.5 Hz, 
H6ax); 1.89 (3H, s, Me); 2.12 (2H, m, H1 H8eq), 2.33 (2H, m, 2H2); 2.65 (1H, ddd, J = 14.4, 3.5, 2.2 Hz, H6eq); 3.77 (1H, 
dddd,, J = 2.9, 2.9, 2.9, 2.9 Hz, H7eq); 3.94 (1H, dq, J = 10.7, 7.1 Hz, OCH2CH3); 3.94 (1H, m, H8a); 4.04 (1H, dq, J = 
10.7, 7.1 Hz, OCH2CH3); 4.40 (1H, d, J = 11.9 Hz, CH2Ph); 4.51 (1H, d, J = 11.9 Hz, CH2Ph); 7.29 (5H, m, Ar). 
13C 
NMR (75 MHz, CDCl3) C 14.0 (CH3CH2); 26.0 (Me); 26.6 (C1); 31.9 (C2); 36.7 (C8); 40.4 (C6); 52.1 (C8a); 59.2 C5); 
61.3 (OCH2CH3); 70.1 (CH2Ph); 70.7 (C7); 127.2 (2CAr); 127.5 (CAr); 128.3 (CAr); 138.5 (CArquat); 173.1 177.7 (CO 
C3). IR (NaCl disc, cm
-1): max = 3460, 2938, 1682, 1455, 1271, 1027, 731. HRMS (ES
+, [MNa]+): Calcd for 
C19H25NO4 354.1681 Found 354.1665. 
(2R*,5S*,7R*,8aR*)-2-allyl-7-benzyloxy-5-methyl-3-oxo-octahydro-indolizin-5-carboxylic acid ethyl ester 36 and 
(2S*,5S*,7R*,8aR*)-2-allyl-7-benzyloxy-5-methyl-3-oxo-octahydro-indolizin-5-carboxylic acid ethyl ester 37 
The same experimental procedure as described for allylation was applied to 35 (1.5 g; 4.53 mmol) using KHMDS 0.5 
M (9.5 mL; 4.75 mmol, 1.01 equiv) in 40 mL of THF. Stirring was maintained 20 min, after cooling to -110 °C, 
addition of distillated allyl bromide (470 L; 5.4 mmol; 1.2 equiv) stirring was continued 1h, then 3h30 at -78 °C. 
Flash chromatography on silica gel (AcOEt/cyclohexane: 50/50) allowed the isolation of 36 as a pale yellow oil (561 
g, 33%) and 37 as a pale yellow oil (366 mg, 22%). Starting material was also recorved (35%). 
36: Rf = 0.33 (Et2O/cyclohexane: 50/50) 
1H NMR (CDCl3, 300 MHz): δH 1.13 (3H, t, J = 7.1 Hz; CH3CH2); 1.20 (1H, 
q, J = 10.9 Hz, H1); 1.32 (1H, ddd, J = 14.6, 12.2, 2.4 Hz, H8ax); 1,56 (1H, dd, J = 14.4, 2.4 Hz, H6ax); 1.90 (3H, s, 
Me); 2.18 (3H, m, CH2CH=CH2 H1 H8eq); 2.48 (1H, m, H2); 2.66 (1H, ddd, J = 14.4, 3.4, 1.8 Hz, H6equ); 2.68 (1H, m, 
CH2CH=CH2); 3.77 (1H, bs, H7equ); 3.88 (1H, m, H8a); 3.93 (1H, dq, J = 10.7, 7.1 Hz, OCH2CH3); 4.04 (1H, dq, J = 
10.7, 7.1 Hz, OCH2CH3); 4.40 (1H, d, J = 11.9 Hz, CH2Ph); 4.52 (1H, d, J = 11.9 Hz, CH2Ph); 5.04 (1H, bd, J = 17 
Hz, CH2CH=CH2); 5.09 (1H, bd, J = 17 Hz, CH2CH=CH2); 5.80 (1H, dddd, J = 17, 10.1, 6.9, 6.9 Hz, CH2CH=CH2); 
7.28 (5H, m, Ar). 13C NMR (75 MHz, CDCl3) C 13.9 (CH3CH2); 26.2 (Me); 32.8 (C1); 35.0 (CH2CH=CH2); 36.5 
(C8); 40.2 (C6); 42.1 (C2); 49.9 (C8a); 59.1 (C5); 61.3 (OCH2CH3); 70.0 (CH2Ph); 70.6 (C7); 116.4 (CH2CH=CH2); 
127.1 (2CAr); 127.4 (CAr); 128.2 (2CAr); 136.0 (CH2CH=CH2); 138.5 (CArquat); 173.1 178.5 (CO C3). IR (NaCl disc, 
cm-1): max = 2925, 1737, 1698, 1454, 1396, 1307, 1274, 1207, 1130, 1028, 913, 736. MS (ES
+): m/z 394 ([MNa]+). 
Anal. Calcd. for:, C22H29NO4 C, 71.13; H, 7.87; N, 3.77. Found: C, 71.52; H, 7.96; N 3.77. 
 
37: Rf = 0.2 (Et2O/cyclohexane: 50/50) 
1H NMR (CDCl3, 300 MHz): δH 1.14 (3H, t, J = 7.2 Hz; CH3CH2); 1.34 (1H, 
ddd, J = 13.3 12.3, 2.5 Hz, H8ax); 1,54 (1H, dd, J = 14.4, 2.5 Hz, H6ax); 1.60 (1H, m, H1); 1.89 (3H, s, Me); 1.97 (1H, 
dd, J = 12.7, 6.0 Hz, H1); 2.10 (1H, ddd, J = 13.4, 13.4, 13.4 Hz, H8eq); 2.28 (1H, m, CH2CH=CH2); 2.45 (1H, m, H2); 
2.50 (1H, m, CH2CH=CH2); 2.64 (1H, ddd, J = 14.4, 3.3, 2.2 Hz, H6equ); 3.76 (1H, q, J = 2.7 Hz, H7); 3.95 (1H, dq, J 
= 10.8, 7.1 Hz, OCH2CH3); 3.98 (1H, m, H8a); 4.04 (1H, dq, J = 10.7, 7.1 Hz, OCH2CH3); 4.38 (1H, d, J = 11.9 Hz, 
CH2Ph); 4.52 (1H, d, J = 11.9 Hz, CH2Ph); 5.06 (1H, bd, J = 10.1 Hz, CH2CH=CH2); 5.09 (1H, dd, J = 17.1, 1.4 Hz, 
CH2CH=CH2); 5.85 (1H, dddd, J = 17, 10.1, 7.8, 6.0 Hz, CH2CH=CH2); 7.28 (5H, m, Ar). 
13C NMR (75 MHz, 
CDCl3) C 14.0 (CH3CH2); 25.9 (Me); 30.7 (C1); 34.7 (CH2CH=CH2); 36.8 (C8); 40.2 (C6); 41.9 (C2); 50.0 (C8a); 59.0 
(C5); 61.3 (OCH2CH3); 70.1 (CH2Ph); 70.6 (C7); 116.7 (CH2CH=CH2); 127.2 (2CAr); 127.5 (CAr); 128.3 (2CAr); 136.4 
(CH2CH=CH2); 138.3 (CArquat); 173.0 178.8 (CO C3). IR (NaCl disc, cm
-1): max = 2937, 1736, 1694, 1446, 1396, 
1276, 1208, 1132, 1067, 912, 729. MS (ES+): m/z 394 ([MNa]+). 
(2R*,5S*,7R*,8aR*)-7-benzyloxy-2-(3-bis(tert-butyloxycarbonyl)guanidino-propyl-5-methyl- -3-oxo-octahydro-
indolizin-5-carboxylic acid ethyl ester 38 
-trans intermediate alcohol: 
The same experimental procedure as described for hydoboration was applied to alkene 36 (309 mg; 0.83 mmol) using a 
0.5 M solution of 9-BBN in THF (5 mL; 2.49 mmol; 3 equiv). Stirring was maintained 16 h after addition of sodium 
acetate 5 M (2 mL, 9.9 mmol, 12 equiv) and a 30 % H2O2 solution (1 mL; 12 equiv). Flash chromatography on silica 
gel (AcOEt/cyclohexane: 90/10) allowed the isolation of a yellow oil (60%, 193 mg). 
Rf = 0.24 (AcOEt/cyclohexane: 95/5) 
1H NMR (CDCl3, 300 MHz): δH 1.09 (3H, t, J = 7.1 Hz; CH3CH2); 1.17 (1H, 
ddd, J = 11.4, 11.4, 11.4 Hz, H1); 1.31 (1H, ddd, J = 13.9, 11.4, 2.4 Hz, H8ax); 1.44 (1H, m, CH2CH2CH2OH); 1,54 
(1H, dd, J = 14.3, 2.3 Hz, H6); 1.6 (2H, m,CH2CH2CH2OH); 1.78-1.95 (4H, s, Me CH2CH2CH2OH); 2.14 (1H, dm, J 
= 11.4 Hz, H8); 2.25 (1H, ddd, J = 11.5, 7.9, 5.4 Hz, H1); 2.38 (1H, m, H2); 2.62 (1H, bd, J = 14.4 Hz, H6); 3.6 (2H, t, 
J = 6.3 Hz, CH2CH2CH2OH); 3.75 (1H, m, H7); 3.85 (1H, m, H8a); 3.93 (1H, dq, J = 10.7, 7.1 Hz, OCH2CH3); 3.97 
(1H, dq, J = 10.7, 7.1 Hz, OCH2CH3); 4.38 (1H, d, J = 11.9 Hz, CH2Ph); 4.49 (1H, d, J = 11.9 Hz, CH2Ph); 7.29 (5H, 
m, Ar). 13C NMR (75 MHz, CDCl3) C 13.9 (CH3CH2); 26.1 (Me); 26.6 (CH2CH2CH2OH); 30.1 (CH2CH2CH2OH); 
33.3 (C1); 36.4 (C8); 40.2 (C6); 42.2 (C2); 50.0 (C8a); 59.1 (C5); 61.3 (OCH2CH3); 62.1 (CH2CH2CH2OH); 70.0 
(CH2Ph); 70.5 (C7); 127.1 (2CAr); 127.4 (CAr); 128.2 (2CAr); 138.3 (CArquat); 173.0 179.7 (CO C3). IR (NaCl disc, cm
-
1): max = 3412, 2928, 1734, 1681, 1399, 1307, 1273, 1210, 1131, 735. MS (ES
+): m/z 412 ([MNa]+). 
The same experimental procedure as described for 25 was applied to intermediate trans (300 mg; 0.77 mmol) using 
and 1,3-bis(tert-butoxycarbonyl) guanidine (311 mg, 1.2 mmol, 1.5 equiv), triphenylphosphine (315 mg, 1.2 mmol, 1.5 
equiv) and diethylazodicarboxylate (DEAD) (190 µL, 1.2 mmol, 1.5 equiv). Stirring was continued for 24 h. Flash 
chromatography on silica gel (Et2O/cyclohexane: 50/50) allowed the isolation of 38 as a white solid (436 mg, 90%). 
Rf = 0.27 (Et2O/cyclohexane: 50/50). mp: 132 °C 
1H NMR (CDCl3, 300 MHz): δH 1.04 (3H, t, J = 7.1 Hz; CH3CH2); 
1.07 (1H, m, H1); 1.25 (2H, m, CH2CH2CH2N H8); 1,4-1.55 (19H, m, 2C(CH3)3 H6); 1.58 (2H, m,CH2CH2CH2N); 
1.81 (3H, s, Me); 1.85 (1H, m, CH2CH2CH2N); 2.08 (1H, bd, J = 12.5 Hz, H8); 2.34 (2H, m, H2, H1); 2.59 (1H, bd, J = 
14.2 Hz, H6); 3.62-3.75 (2H, m, H7, CH2CH2CH2N); 3.75-3.89 (2H, H8a, OCH2CH3); 3.89-4.0 (2H, m, CH2CH2CH2N 
OCH2CH3); 4.32 (1H, d, J = 11.9 Hz, CH2Ph); 4.45 (1H, d, J = 11.9 Hz, CH2Ph); 7.21 (5H, m, Ar); 9.22 (2H, m, 
NH2). 
13C NMR (75 MHz, CDCl3) C 13.9 (CH3CH2); 26.1 (Me); 27.6 (CH2CH2CH2N); 28.0 and 28.3 (CH2CH2CH2N, 
2C(CH3)3); 33.1 (C1); 36.5 (C8); 40.3 (C6); 42.0 (C2); 44.3 (CH2CH2CH2N); 49.9 (C8a); 59.0 (C5); 61.2 (OCH2CH3); 
69.9 (CH2Ph); 70.5 (C7); 78.4 (C(CH3)3); 83.6 (C(CH3)3); 127.0(2CAr); 127.3 (CAr); 128.2 (2CAr); 138.3 (CArquat); 
155.0; 160.5; 163.8 (C=N, NCOO); 173.0 179.1 (CO C3). IR (NaCl disc, cm-1): max = 3390, 2881, 1714, 1608, 1271, 
1150. MS (ES+): m/z 653 ([MNa]+). 
(2S*,4R*,6R*)-6-[(2R*)-2-carboxy-5-guanidino-pentyl]-4-hydroxy-2-methyl-piperidin-2-carboxylic acid 39 
Compound 38 (70 mg, 0.11 mmol) was dissolved in 5 mL of HCl 3 M. The mixture was refluxed for 20 h. The solvent 
was evapored under vacuo. To the residue were added 1 mL of diethyl ether and 2 mL of watter, insoluble solids were 
filterated and the product was extracted 3 times with 2 mL of water. The aqueous phase was lyophilysed to leave an 
orange oil in a 100% yield (38 mg). 
1H NMR (D2O, 400 MHz): δH 1.3-1.65 (8H, m, CH2CHCOOH H5 Me, CH2CH2CH2N); 1.67 (1H, bd, J = 15.0 Hz, 
H3); 1.75-1.95 (3H, m, CH2CH2CH2N CH2CHCOOH H5); 2.3-2.5 (2H, m, H3 CH2CHCOOH); 3.0 (2H, bs, 
CH2CH2CH2N); 3.67 (1H, m, H6); 4.05 (1H, bs, H4). 
13C NMR (75 MHz, D2O) C 24.4 (Me); 25.4 (CH2CH2CH2N); 
28.7 (CH2CH2CH2N); 33.2 (C5); 34.4 (CH2CHCOOH); 37.8 (C3); 40.7 (CH2CHCOOH CH2CH2CH2N); 47.5 (C6); 
59.2 (C2); 61.7 (C4); 156.6 (C=N); 173.8 178.6 (CO C3). MS (ES
+): m/z 313 ([M-H2O]
+), 331 ([M-H]+). HRMS (ES+, 
[MH]+): Calcd for C14H26N4O5 331.1981 Found 331.1965. 
(2S*,5S*,7R*,8aR*)-7-benzyloxy-2-(3-bis(tert-butyloxycarbonyl)guanidino-propyl-5-methyl- -3-oxo-octahydro-
indolizin-5-carboxylic acid ethyl ester 40 
-cis intermediate alcohol: 
The same experimental procedure as described for hydroboration was applied to alkene 37 (178 mg; 0.48 mmol) using 
a 0.5 M solution of 9-BBN in THF (2 mL; 1 mmol; 2.1 equiv). Stirring was maintained 16 h after addition of sodium 
acetate 5 M (1.15 mL, 5.76 mmmol, 12 equiv) and a 30 % H2O2 solution (0.6 mL; 5.76 mmol, 12 equiv). Flash 
chromatography on silica gel (AcOEt/Et2O: 90/10) allowed the isolation of a yellow oil (87%, 162 mg). 
Rf = 0.18 (AcOet/Et2O: 90/10) 
1H NMR (CDCl3, 300 MHz): δH 1.15 (3H, t, J = 7.1 Hz; CH3CH2); 1.34 (1H, ddd, J = 
13.6 11.2, 2.4 Hz, H8); 1,57 (1H, dd, J = 14.4, 2.5 Hz, H6); 1.61-1.96 (9H, m, Me CH2CH2CH2OH H1); 2.13 (1H, dm, 
J = 13.5 Hz, H8); 2.28 (1H, bs, OH); 2.46 (1H, m, H2); 2.67 (1H, ddd, J = 14.4, 3.4, 2.1 Hz, H6); 3.7 (2H, m, 
CH2CH2CH2OH); 3.78 (1H, m, H7); 3.93-4.09 (3H, m, H8a OCH2CH3); 4.41 (1H, d, J = 11.9 Hz, CH2Ph); 4.53 (1H, d, 
J = 11.9 Hz, CH2Ph); 7.3 (5H, m, Ar). 
13C NMR (100 MHz, CDCl3) C 14.1 (CH3CH2); 26.0 (Me); 27.2 
(CH2CH2CH2OH); 30.5 (CH2CH2CH2OH); 32.4 (C1); 34.7 (CH2CH=CH2); 36.9 (C8); 40.3 (C6); 41.9 (C2); 50.3 (C8a); 
59.1 (C5); 61.5 (OCH2CH3); 62.6 (CH2CH2CH2OH); 70.2 (CH2Ph); 70.6 (C7); 127.3 (2CAr); 127.6 (CAr); 128.4 (2CAr); 
138.4 (CArquat); 173.1 179.6 (CO  C3). IR (NaCl disc, cm
-1): max = 3389, 2952, 1651, 1454, 1286, 1066, 910, 728. MS 
(ES+): m/z 412 ([MNa]+). 
The same experimental procedure as described for 25  was applied to intermadiate cis (24 mg; 0.062 mmol) using and 
1,3-bis(tert-butoxycarbonyl) guanidine (26 mg, 0.1 mmol, 1.6 equiv), triphenylphosphine (26 mg, 0.1 mmol, 1.6 
equiv) and diethylazodicarboxylate (DEAD) (16 µL, 0.1 mmol, 1.6 equiv). Stirring was continued for 44 h. Flash 
chromatography on silica gel (Et2O/cyclohexane: 70/30) allowed the isolation of 40 as a white solid (40 mg, 100%). 
Rf = 0.31 (AcOet/Et2O: 70/30). mp>60 °C 
1H NMR (CDCl3, 300 MHz): δH 1.13 (3H, t, J = 7.2 Hz; CH3CH2); 1.31 
(1H, m, H8); 1,41-1.62 (20H, m, CH2CH2CH2N 2C(CH3)3 H6); 1,63-1.62 (4H, m, CH2CH2CH2N H1); 1.95 (4H, m, 
Me, H1); 2.12 (1H, bd, J = 13.4 Hz, H8); 2.4 (1H, m, H2); 2.67 (1H, bd, H6); 3.78 (1H, bs, H7); 3.82-4.09 (5H, m, 
CH2CH2CH2N H8a OCH2CH3); 4.39 (1H, d, J = 12 Hz, CH2Ph); 4.52 (1H, d, J = 12 Hz, CH2Ph); 7.3 (5H, m, Ar); 9.23 
(2H, bs, NH2). 
13C NMR (75 MHz, CDCl3) C 14.0 (CH3CH2); 25.9 (Me); 26.8 and 27.3 (CH2CH2CH2N, 
CH2CH2CH2N); 28.0 and 28.3 (2C(CH3)3); 31.6 (C1); 36.9 (C8); 40.2 (C6); 42.0 (C2); 44.5 (CH2CH2CH2N); 50.1 
(C8a); 59.0 (C5); 61.3 (OCH2CH3); 70.0 (CH2Ph); 70.6 (C7); 78.6 (C(CH3)3); 83.7 (C(CH3)3); 127.2 (2CAr); 127.5 
(CAr); 128.3 (2CAr); 138.3 (CArquat); 155.1, 156.8, 163.9 (C=N, NCOO); 173.0 179.2 (CO C3). IR (NaCl disc, cm
-1): 
max = 3382, 2930, 1714, 1614, 1454, 1359, 1255, 1152. MS (ES
+): m/z 631 ([MNa]+). 
(2S*,4R*,6R*)-6-[(2S*)-2-carboxy-5-guanidino-pentyl]-4-hydroxy-2-methyl-piperidin-2-carboxylic acid 41 
The same experimental procedure as described for 39 was applied to 40 (67 mg; 0.1 mmol) in 5 mL of HCl 3 M. The 
aqueous phase was lyophilysed to leave brown oil in a 100% yield (44 mg). 
1H NMR (D2O, 400 MHz): δH); 1.45 (3H, s, Me); 1.46-1.6 (5H, m, CH2CHCOOH H5 CH2CH2CH2N); 1.75 (1H, bd, J 
= 14.4 Hz, H3); 1.78-1.93 (3H, m, CH2CH2CH2N CH2CHCOOH H5); 2.48 (1H, bd, , J = 15.1 Hz, H3); 2.58 (1H, q, J 
= 6.4 Hz, CH2CHCOOH); 3.09 (2H, t, J = 6.5 Hz, CH2CH2CH2N); 3.75 (1H, m, H6); 4.09 (1H, bs, H4). 
13C NMR (75 
MHz, D2O) C 24.5 (Me); 25.2 (CH2CH2CH2N); 28.2 (CH2CH2CH2N); 33.5 (C5); 34.1 (CH2CHCOOH); 37.7 (C3); 
40.7 (CH2CH2CH2N); 40.9 ((CH2CHCOOH); 47.8 (C6); 59.4 (C2); 61.8 (C4); 156.6 (C=N); 174.1 179.1 (CO C3). MS 
(ES+): m/z  331 ([M-H]+). HRMS (ES+, [MH]+): Calcd for C14H26N4O5 331.1981 Found 331.1965. 
Cell culture and cell adhesion assay 
S180 and Eahy926 cells were cultured in DMEM+10% FCS and DMEM+20%FCS+HAT, respectively. For adhesion 
assays, cells were harvested with cell dissociation non-enzymatic solution (SIGMA). Cells were pelleted by 
centrifugation and resuspended at a density of 1x105 cells/ml in PBS/CaMg. Assays of cell adhesion to coated 
substrates were performed on non-tissue culture treated 96-well plates,. The wells were incubated with FN or VN at 10 
g.ml-1 in PBS overnight at 4 °C followed by a 30-min incubation with 3 mg.ml-1 bovine serum albumin in PBS 
(previously heat-inactivated for 3 min at 80 °C). The substrates were thoroughly washed and maintained in PBS until 
use. The peptidomimetics solutions were prepared either at 20 M, 400 M or 1 mM in PBSCaMg. 50 l of 
peptidomimetic solution were added to the well with 50 l of the cell suspension reaching the final peptidomimetic 
solution to 10 M, 200 M or 500 M), for the assay. Each test was done in triplicate. The plates were incubated at 37 
°C for 1 h, washed with PBS to remove the non adherent cells. Then, the wells were fixed in 5% glutaraldehyde in 
PBS, washed, stained with 1% crystal violet in 200 mM MES and washed in 200 mM MES buffer, pH 6. The crystal 
violet fixed to the cells was dissolved in 100 L of 10% acetic acid and OD was read with a microplate reader at 570 
nm. Data are the mean±S.D of triplicates and are expressed as the % of cell adhesion obtained on FN in the absence of 
competitor. The positive and negative controls for the inhibition of cell adhesion were done using the cyclic c(RGDfV) 
and GRGES peptides, respectively. Two independent experiments were done for each co mpetitor and for each cell 
type. 
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